{"meta":{"query_hash":"9b96a8b6e89a","filters":{"venue":"Expert Opinion on Drug Metabolism & Toxicology"},"cohort_total":77,"direct_labels_cover":0,"predictions_cover":77,"exported":77,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9b96a8b6e89a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Drug+Metabolism+%26+Toxicology"},"results":[{"id":"W1820440715","doi":"10.1517/17425255.2015.1085506","title":"Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Pharmacodynamics; Medicine; Pharmacokinetics; Cancer; Oncology; Pharmacology; Internal medicine","score_opus":0.08517929021166616,"score_gpt":0.4622642591928121,"score_spread":0.37708496898114596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1820440715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050646527,0.9972466,0.00018315791,0.0005397061,0.00013719779,0.000008318843,0.00005560149,0.0000079364345,0.0013150284],"genre_scores_gemma":[0.004758668,0.99307805,0.00028700355,0.00047789107,0.00027596415,0.00001079989,0.00008036408,0.0000027735011,0.0010284994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998148,0.000038646773,0.00002134546,0.00003345263,0.00007951598,0.000012331689],"domain_scores_gemma":[0.9997677,0.000109946115,0.000060501254,0.000004675386,0.000045635657,0.000011492924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004692723,0.00039953293,0.0007662092,0.00088307704,0.000106483894,0.000545364,0.0004401189,0.0005879483,0.0041001844],"category_scores_gemma":[0.0006148967,0.000117157724,0.0005345759,0.00081132416,0.00017443667,0.00041084873,0.00020101585,0.000901263,0.0014160885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002068576,0.00006540768,0.00037735587,0.017123995,0.00018404333,0.0002946408,0.00004211751,0.000523681,0.0040719802,0.0018769563,0.023077298,0.9521556],"study_design_scores_gemma":[0.00010522822,0.0005870289,0.0030397412,0.005324205,0.00044390233,0.004258052,0.000060010432,0.00037573485,0.002619306,0.0018237585,0.98132527,0.000037751925],"about_ca_topic_score_codex":0.00065174635,"about_ca_topic_score_gemma":0.0011311166,"teacher_disagreement_score":0.0041001844,"about_ca_system_score_codex":0.00028782606,"about_ca_system_score_gemma":0.00044029494,"threshold_uncertainty_score":0.013716459},"labels":[],"label_agreement":null},{"id":"W1963303504","doi":"10.1517/17425255.2015.1075003","title":"Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Alliance for Research on Schizophrenia and Depression","keywords":"Clozapine; Pharmacogenetics; Schizophrenia (object-oriented programming); Medicine; Adverse effect; Psychiatry; Pharmacology; Intensive care medicine; Bioinformatics; Genotype; Biology; Genetics; Gene","score_opus":0.07381019164683754,"score_gpt":0.4236885365414994,"score_spread":0.34987834489466185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963303504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007685192,0.9959008,0.00023754124,0.0020447297,0.00023485128,0.0000063035905,0.00014722359,0.00001405854,0.00064599357],"genre_scores_gemma":[0.0058910935,0.9909994,0.0005805941,0.001218686,0.00082194735,0.000014358088,0.00020693807,0.0000053546037,0.00026152263],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995431,0.00012542937,0.00012824645,0.00007442963,0.000106059066,0.000022790378],"domain_scores_gemma":[0.99724764,0.0017481861,0.00042042538,0.00004495761,0.00047733713,0.00006143218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001208903,0.000581095,0.0013671494,0.0018352239,0.000142325,0.0010804748,0.0004970895,0.00079441234,0.002040369],"category_scores_gemma":[0.0033060152,0.00018630923,0.00093357166,0.0017677298,0.00030756884,0.0007654724,0.00039555613,0.0009888418,0.0004152649],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002588408,0.000035288544,0.0056992057,0.016158747,0.00082948175,0.00036619802,0.00007667631,0.00026345358,0.00063062616,0.0011142658,0.027904438,0.9466628],"study_design_scores_gemma":[0.00021122921,0.00040333223,0.058173336,0.036233272,0.007764541,0.0077462504,0.00023891506,0.000809573,0.00088396465,0.005051023,0.8823545,0.0001300709],"about_ca_topic_score_codex":0.0032760438,"about_ca_topic_score_gemma":0.0060187443,"teacher_disagreement_score":0.0032760438,"about_ca_system_score_codex":0.0008428085,"about_ca_system_score_gemma":0.0012720738,"threshold_uncertainty_score":0.0068256855},"labels":[],"label_agreement":null},{"id":"W1965212674","doi":"10.1517/17425255.4.6.783","title":"Octreotide LAR for the treatment of acromegaly","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Acromegaly; Octreotide; Medicine; Internal medicine; Somatostatin; Intensive care medicine; Growth hormone; Hormone","score_opus":0.06689991666437217,"score_gpt":0.38342386655132854,"score_spread":0.31652394988695637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965212674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020008841,0.9986345,0.00008337625,0.00016789818,0.000112753325,0.0000048563165,0.000008042228,0.0000049251494,0.0007834346],"genre_scores_gemma":[0.001297571,0.99762386,0.00018560761,0.00021719481,0.00018211488,0.0000057934685,0.000017051547,0.0000010338297,0.00046970576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981624,0.000039197294,0.000027577375,0.00002572306,0.00007611068,0.000015139902],"domain_scores_gemma":[0.9997799,0.00009001059,0.00006565694,0.0000041842586,0.000041863044,0.000018417046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004294958,0.00064186985,0.0012236784,0.002041481,0.00016100942,0.00050196145,0.00052746054,0.0007880338,0.003540121],"category_scores_gemma":[0.00048090972,0.00014093844,0.00042508173,0.0016253531,0.00026903144,0.0004991695,0.00026102975,0.00072480785,0.002042202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013053806,0.000057320325,0.00028847286,0.018325837,0.00015618352,0.0009873183,0.000048811635,0.0001665836,0.0034750076,0.0007639594,0.02041555,0.9551845],"study_design_scores_gemma":[0.00016190458,0.00048296753,0.0033239028,0.009916567,0.0006750117,0.016690664,0.0001522247,0.00016819316,0.002523883,0.001397251,0.9644707,0.000036721718],"about_ca_topic_score_codex":0.00082284055,"about_ca_topic_score_gemma":0.0017821395,"teacher_disagreement_score":0.003540121,"about_ca_system_score_codex":0.0003499725,"about_ca_system_score_gemma":0.00071370415,"threshold_uncertainty_score":0.0118429065},"labels":[],"label_agreement":null},{"id":"W1967122702","doi":"10.1517/17425255.1.4.655","title":"Drug-induced mitochondrial toxicity","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitochondrion; Mitochondrial permeability transition pore; Oxidative phosphorylation; Programmed cell death; Mitochondrial DNA; Mitochondrial toxicity; Oxidative stress; Cell biology; Biology; Apoptosis; Mitochondrial respiratory chain; Cytochrome c; Respiratory chain; Biochemistry; Pharmacology; Gene","score_opus":0.03520963181503899,"score_gpt":0.3475526792584428,"score_spread":0.3123430474434038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967122702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009754512,0.98674446,0.0010384356,0.00068805396,0.00054995617,0.000029295421,0.00009052051,0.00008026337,0.009803464],"genre_scores_gemma":[0.007520427,0.9825798,0.0007106869,0.0009817128,0.00029783603,0.000034631674,0.00015137634,0.00001100745,0.007712544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977213,0.000039804374,0.000019888972,0.000044200588,0.00009985084,0.000024113973],"domain_scores_gemma":[0.9998524,0.00003883096,0.000037297952,0.0000087581,0.000044394415,0.0000183171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031948977,0.0011464696,0.0014855695,0.001296778,0.0003691532,0.00090628554,0.000850018,0.0015386216,0.0058721937],"category_scores_gemma":[0.0002826435,0.00017092247,0.0005296102,0.0010694824,0.000502347,0.0007340627,0.0007676767,0.0010362451,0.0053000897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089640365,0.000105077816,0.00032892308,0.013038542,0.00012347587,0.0028649252,0.00009089739,0.0005883453,0.02588359,0.007783249,0.07503494,0.87406844],"study_design_scores_gemma":[0.00003363137,0.00016734241,0.001136124,0.0013797977,0.00008109402,0.012214742,0.000055916487,0.00017434795,0.011185773,0.003483718,0.9700614,0.000025975922],"about_ca_topic_score_codex":0.00065305206,"about_ca_topic_score_gemma":0.0011687201,"teacher_disagreement_score":0.0058721937,"about_ca_system_score_codex":0.00097162055,"about_ca_system_score_gemma":0.00048829656,"threshold_uncertainty_score":0.01964444},"labels":[],"label_agreement":null},{"id":"W1979971952","doi":"10.1517/17425250903124355","title":"Budesonide for Crohn's disease","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Izaak Walton Killam Health Centre; Dalhousie University; Hospital for Sick Children; Mount Sinai Hospital","funders":"","keywords":"Budesonide; Medicine; Crohn's disease; Gastrointestinal tract; Disease; Adverse effect; Inflammatory bowel disease; Inflammation; Gastroenterology; Internal medicine; Bioavailability; Corticosteroid; Immunology; Pharmacology","score_opus":0.02897758827155749,"score_gpt":0.34638869951792844,"score_spread":0.31741111124637095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979971952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000210901,0.9947573,0.0002937451,0.00070118613,0.000755012,0.000014270173,0.000031989362,0.000021351232,0.0032143372],"genre_scores_gemma":[0.001308668,0.99328786,0.00044343315,0.0006396216,0.0005582554,0.000015470032,0.00007894914,0.0000043043538,0.003663423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997645,0.000037914,0.000021550273,0.00003725173,0.00011857705,0.0000201445],"domain_scores_gemma":[0.99984443,0.000043244705,0.000032004395,0.0000065849904,0.000044356817,0.000029340667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004744326,0.00085529935,0.0015936405,0.0015829697,0.0002904534,0.0007350423,0.0010085636,0.0014356606,0.005602139],"category_scores_gemma":[0.00042751752,0.00020402623,0.00044692415,0.0013893573,0.0003878444,0.0008683346,0.00056884147,0.00193446,0.009245426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092230155,0.000071035094,0.0001184776,0.007137142,0.00006799166,0.00063658925,0.000039110586,0.0001899816,0.0039956667,0.0017760568,0.07261282,0.91326296],"study_design_scores_gemma":[0.000051185147,0.000078793884,0.00046783176,0.0011970263,0.00004422496,0.0024074384,0.000021926477,0.000056632372,0.0004369726,0.0009519247,0.99427444,0.000011599521],"about_ca_topic_score_codex":0.00073617836,"about_ca_topic_score_gemma":0.0020924222,"teacher_disagreement_score":0.005602139,"about_ca_system_score_codex":0.0004929143,"about_ca_system_score_gemma":0.0005602148,"threshold_uncertainty_score":0.018741071},"labels":[],"label_agreement":null},{"id":"W1983589764","doi":"10.1517/17425255.2011.553188","title":"Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Syncytiotrophoblast; Organic cation transport proteins; Medicine; Diabetes mellitus; Placenta; Drug; Pregnancy; Pharmacology; Transporter; Rosiglitazone; Bioinformatics; Biology; Fetus; Endocrinology; Genetics; Gene","score_opus":0.06221032364590644,"score_gpt":0.3524260527569389,"score_spread":0.29021572911103244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983589764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027788398,0.9975198,0.00018458813,0.0009388514,0.0001562333,0.0000029492683,0.000025308467,0.000006794942,0.0008875991],"genre_scores_gemma":[0.0014615828,0.9972656,0.00021616953,0.00026804826,0.00018023096,0.0000048045686,0.000028771738,0.0000011921551,0.00057364505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979204,0.000053997308,0.000026223064,0.00003987135,0.000070895854,0.000017011631],"domain_scores_gemma":[0.99968326,0.00017115426,0.000054334774,0.0000068022023,0.00006920898,0.00001525915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041830193,0.0005344205,0.0012451493,0.00079929444,0.00012825402,0.00060008693,0.0005091281,0.0010821187,0.0030016848],"category_scores_gemma":[0.0006782858,0.00013853596,0.0004378719,0.0010849563,0.0003054089,0.0006128685,0.00031699036,0.0009002005,0.0015731981],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011556228,0.00004620827,0.0007655838,0.011634504,0.00011943229,0.0010284142,0.000056911565,0.0003055228,0.0025997884,0.0023225565,0.028063204,0.9529423],"study_design_scores_gemma":[0.00005493405,0.00021992027,0.004753849,0.006464676,0.00032922922,0.011997613,0.00015215849,0.00027380302,0.0018109109,0.0037279294,0.97017705,0.0000378048],"about_ca_topic_score_codex":0.0010137396,"about_ca_topic_score_gemma":0.0013382776,"teacher_disagreement_score":0.0030016848,"about_ca_system_score_codex":0.0004161782,"about_ca_system_score_gemma":0.0006279638,"threshold_uncertainty_score":0.010041654},"labels":[],"label_agreement":null},{"id":"W1984101371","doi":"10.1517/17425255.2010.530656","title":"Pharmacokinetic evaluation of idebenone","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Idebenone; Pharmacology; Chemistry; Pharmacokinetics; Metabolite; Antioxidant; Biochemistry; Medicine","score_opus":0.14544719812762152,"score_gpt":0.4364099275969944,"score_spread":0.29096272946937285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984101371","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51182216,0.34059876,0.08593503,0.0049590473,0.0019724465,0.0011876246,0.010468569,0.0012354666,0.041820887],"genre_scores_gemma":[0.8934924,0.072681464,0.012473789,0.0022166467,0.0008504993,0.00040382787,0.0039026488,0.00031798362,0.013660741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994615,0.0001902815,0.00003239081,0.00010131694,0.00019087836,0.000023689712],"domain_scores_gemma":[0.9993185,0.00023405804,0.00016743141,0.000051923118,0.00017474621,0.00005342664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010279327,0.00041847522,0.0006880921,0.0003641137,0.00015387313,0.0007918601,0.00027153906,0.00053156615,0.0035429564],"category_scores_gemma":[0.0021806944,0.00020748824,0.00050680013,0.0004713397,0.00026291853,0.0004869187,0.00022400763,0.0012747135,0.0012635918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015302165,0.00074723136,0.028071355,0.005623134,0.0014379311,0.001945593,0.0006400918,0.0055802194,0.35227454,0.004096351,0.021437412,0.56284404],"study_design_scores_gemma":[0.0019424864,0.023990711,0.09888157,0.00121123,0.0028075872,0.018984767,0.0004442992,0.01718277,0.3334306,0.0053077233,0.49549615,0.00032013998],"about_ca_topic_score_codex":0.0006191434,"about_ca_topic_score_gemma":0.0006686383,"teacher_disagreement_score":0.0035429564,"about_ca_system_score_codex":0.00044166553,"about_ca_system_score_gemma":0.00078404974,"threshold_uncertainty_score":0.011852384},"labels":[],"label_agreement":null},{"id":"W1989226681","doi":"10.1517/17425255.2011.586630","title":"The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Université de Montréal","funders":"","keywords":"Hypoxia (environmental); Pharmacology; Cytochrome P450; Gene isoform; Biology; Drug; Drug action; Cell biology; Chemistry; Biochemistry; Enzyme; Gene","score_opus":0.1443570859063354,"score_gpt":0.4785649180725097,"score_spread":0.33420783216617433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989226681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006578715,0.99593985,0.00040037773,0.00079143053,0.0002830142,0.000007140112,0.00006070432,0.000013254877,0.001846323],"genre_scores_gemma":[0.004432728,0.99220216,0.00032668634,0.00036036345,0.00042515653,0.000012996637,0.000098966455,0.0000031964926,0.0021376908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985147,0.000031313215,0.000014290302,0.00003154572,0.000056128363,0.000015243243],"domain_scores_gemma":[0.9998431,0.00005423836,0.000036821613,0.000004823321,0.000050960043,0.000009925556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002642051,0.0004944387,0.0007957159,0.0005904608,0.0001401336,0.0005079391,0.0003864786,0.0007847748,0.0036308717],"category_scores_gemma":[0.00037451668,0.00012550662,0.0003046493,0.0007905293,0.00025940966,0.0005817394,0.00025878023,0.000754341,0.0020687042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001348878,0.000043874297,0.00046531647,0.012635863,0.00008508052,0.00042876162,0.000051605723,0.0002836069,0.0113131665,0.0024078223,0.029148526,0.94300145],"study_design_scores_gemma":[0.000032067135,0.00029818353,0.00512891,0.0023332054,0.00018528962,0.0056186407,0.000091926166,0.00021642624,0.006840441,0.0027122193,0.9765094,0.000033343495],"about_ca_topic_score_codex":0.00088628026,"about_ca_topic_score_gemma":0.0011799616,"teacher_disagreement_score":0.0036308717,"about_ca_system_score_codex":0.00037686556,"about_ca_system_score_gemma":0.0005590541,"threshold_uncertainty_score":0.012146473},"labels":[],"label_agreement":null},{"id":"W1994470556","doi":"10.1517/17425255.4.4.395","title":"The Caco-2 cell monolayer: usefulness and limitations","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":517,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Monolayer; Caco-2; Drug discovery; Chemistry; Computational biology; Nanotechnology; Cell; Biochemistry; Biology; Materials science","score_opus":0.07196197644650103,"score_gpt":0.33226200390177346,"score_spread":0.2603000274552724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994470556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037486511,0.97117066,0.009131084,0.008706202,0.00088044757,0.00006204688,0.00017050556,0.000062848,0.0060674865],"genre_scores_gemma":[0.02038661,0.9619671,0.012404917,0.0025113942,0.0007404527,0.00015524492,0.00024056066,0.000029221304,0.0015644679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99115294,0.0038725364,0.00071175845,0.0008446495,0.0032030249,0.00021509588],"domain_scores_gemma":[0.9919572,0.0049905637,0.0008161558,0.00038518143,0.0017196645,0.00013118105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00952392,0.0008061631,0.002294222,0.0016697843,0.00046244994,0.002658469,0.0028121916,0.0025172015,0.0013906328],"category_scores_gemma":[0.0056907046,0.00066480617,0.00076364045,0.0019746884,0.0019703421,0.0026941462,0.0010586986,0.0021508785,0.002457978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034768024,0.00012815007,0.0029998336,0.038068634,0.00028021532,0.0018289802,0.0008446221,0.0010557732,0.0753033,0.025575077,0.035757344,0.8178104],"study_design_scores_gemma":[0.00003954637,0.0005086047,0.0044361316,0.0043615554,0.0003461661,0.010335154,0.0011892468,0.001341354,0.04180039,0.010887352,0.9245896,0.00016484727],"about_ca_topic_score_codex":0.0016101849,"about_ca_topic_score_gemma":0.0021028474,"teacher_disagreement_score":0.00952392,"about_ca_system_score_codex":0.0013967628,"about_ca_system_score_gemma":0.0015197905,"threshold_uncertainty_score":0.05036789},"labels":[],"label_agreement":null},{"id":"W1996603307","doi":"10.1517/17425255.2015.1028355","title":"Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Uridine diphosphate; Allosteric regulation; Biochemistry; Glycosylation; Enzyme; Ribosome; Uridine; Chemistry; Function (biology); Phosphorylation; Biology; Cell biology; RNA; Gene","score_opus":0.2114949152708257,"score_gpt":0.4791306733333917,"score_spread":0.267635758062566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996603307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008424997,0.99218494,0.001085279,0.0008885489,0.0005293949,0.000013430526,0.00009841799,0.000036631976,0.004320824],"genre_scores_gemma":[0.0059569506,0.98893905,0.0006968543,0.0005727545,0.00032064787,0.000016694616,0.00022382865,0.000008256234,0.003264946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.000027437067,0.000016764618,0.000043861244,0.000068535286,0.000021895943],"domain_scores_gemma":[0.9998549,0.000040194336,0.000031544685,0.0000047658427,0.000052793916,0.000015658043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031725675,0.00061093376,0.00073084247,0.0007535474,0.00013946243,0.00084388175,0.000469541,0.0008782056,0.0033714462],"category_scores_gemma":[0.00037684117,0.00016092086,0.0003732652,0.00078658655,0.00029793885,0.0007196259,0.0004622637,0.0009808232,0.0023639705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112907765,0.00004245937,0.000333472,0.01345088,0.00009981508,0.0005773392,0.00010038691,0.00072735397,0.025723495,0.010047867,0.037949357,0.91083467],"study_design_scores_gemma":[0.000010843885,0.00006636752,0.00086253753,0.0010565456,0.00006303223,0.0011601626,0.000038374947,0.00019407614,0.007460122,0.0021567864,0.9869127,0.000018444274],"about_ca_topic_score_codex":0.00053466816,"about_ca_topic_score_gemma":0.00068623095,"teacher_disagreement_score":0.0033714462,"about_ca_system_score_codex":0.0006136371,"about_ca_system_score_gemma":0.00067842903,"threshold_uncertainty_score":0.011278629},"labels":[],"label_agreement":null},{"id":"W2006130517","doi":"10.1517/17425255.2014.893294","title":"Pharmacogenetic considerations for acute lymphoblastic leukemia therapies","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Medicine; Exome; Genome-wide association study; Exome sequencing; Candidate gene; Drug; Bioinformatics; Biology; Pharmacology; Gene; Genetics; Single-nucleotide polymorphism; Mutation; Genotype","score_opus":0.06163988902459463,"score_gpt":0.4071019394328113,"score_spread":0.3454620504082167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006130517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076249584,0.995359,0.0003398105,0.0022683707,0.0004008558,0.000008322353,0.000031200743,0.000009755312,0.0015065395],"genre_scores_gemma":[0.0007752588,0.99661106,0.0003873696,0.0010072163,0.0004002298,0.000011192375,0.00005012923,0.0000022888505,0.0007553236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996024,0.00014098344,0.000049015067,0.00005667792,0.00012896754,0.000022055518],"domain_scores_gemma":[0.9993419,0.00039923794,0.00007632521,0.00001905677,0.00013319988,0.000030237381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009642696,0.0006267247,0.0012124827,0.0016305565,0.00021862444,0.0009125225,0.0009727205,0.0014743957,0.00567621],"category_scores_gemma":[0.0015604746,0.00022078544,0.0008140455,0.0014548046,0.0004996074,0.0011473912,0.00065955456,0.0027797748,0.0027315551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056467474,0.000042190062,0.00018695419,0.0119746905,0.00015119003,0.00030882543,0.000045193538,0.0004552307,0.0006491589,0.009336605,0.058026034,0.91876745],"study_design_scores_gemma":[0.000021401462,0.000040928364,0.00043365208,0.00487148,0.000114686096,0.0015768249,0.00003555965,0.00010167323,0.0001999503,0.004906816,0.9876836,0.000013493575],"about_ca_topic_score_codex":0.00097653875,"about_ca_topic_score_gemma":0.0018372813,"teacher_disagreement_score":0.00567621,"about_ca_system_score_codex":0.00087082613,"about_ca_system_score_gemma":0.0010493151,"threshold_uncertainty_score":0.018988788},"labels":[],"label_agreement":null},{"id":"W2017109689","doi":"10.1517/17425255.2011.585968","title":"Have physiologically-based pharmacokinetic models delivered?","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Heartland Health Research Alliance; U.S. Environmental Protection Agency","keywords":"Physiologically based pharmacokinetic modelling; In silico; Pharmacokinetics; Drug development; Drug; Human health; Computational biology; Computer science; Biochemical engineering; Pharmacology; Risk analysis (engineering); Medicine; Biology; Engineering","score_opus":0.2037785665111753,"score_gpt":0.41993476547632874,"score_spread":0.21615619896515345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017109689","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023786865,0.09119985,0.29692575,0.5470275,0.011114883,0.0002866186,0.0010690525,0.0009114803,0.02767802],"genre_scores_gemma":[0.47601226,0.15264179,0.19727446,0.14107567,0.00850197,0.0007507479,0.0015257125,0.00074481533,0.021472557],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99025947,0.0046090353,0.000689243,0.0013921678,0.0026671805,0.00038286095],"domain_scores_gemma":[0.982557,0.007789297,0.0018573535,0.002206211,0.0050248457,0.0005652871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019281436,0.0012261051,0.0025080196,0.00091234903,0.0008026046,0.007044174,0.0021361662,0.006912608,0.0061203474],"category_scores_gemma":[0.050722998,0.0010894571,0.0016662492,0.001063673,0.003829572,0.014735536,0.002345154,0.010195244,0.0060529015],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068756903,0.000428211,0.009239489,0.0031422768,0.00043748203,0.0006276995,0.0021393397,0.03598046,0.008456554,0.44967282,0.052618995,0.43656915],"study_design_scores_gemma":[0.00016067954,0.00095030805,0.00310625,0.0017826536,0.00029685022,0.0011976381,0.0020774063,0.044936847,0.008909954,0.54029864,0.3959104,0.0003724254],"about_ca_topic_score_codex":0.006392593,"about_ca_topic_score_gemma":0.0025905948,"teacher_disagreement_score":0.019281436,"about_ca_system_score_codex":0.005970111,"about_ca_system_score_gemma":0.0061591123,"threshold_uncertainty_score":0.10197115},"labels":[],"label_agreement":null},{"id":"W2020919429","doi":"10.1517/17425250903176439","title":"The effect of oral lipids and circulating lipoproteins on the metabolism of drugs","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bioavailability; Drug; Metabolism; Lipid metabolism; Drug metabolism; Chemistry; Pharmacology; Lipoprotein; Enzyme; Biochemistry; Small intestine; Triglyceride; Cholesterol; Biology","score_opus":0.026940115706661973,"score_gpt":0.33330628757481795,"score_spread":0.30636617186815596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020919429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002437863,0.99740964,0.00019240133,0.00048498722,0.00023351384,0.000005905948,0.000019089195,0.000008489266,0.0014021798],"genre_scores_gemma":[0.00091783144,0.9974414,0.00020850486,0.00022246319,0.00023752013,0.000008411132,0.00003210898,0.000001100204,0.0009306653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999742,0.000043341053,0.00003045695,0.000041270192,0.00011949673,0.000023324666],"domain_scores_gemma":[0.9997191,0.0001088575,0.00005486226,0.000008238452,0.00008767307,0.000021300837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005404503,0.0008650953,0.0020592825,0.001440135,0.00019450355,0.00088905735,0.0009584466,0.0014353886,0.004011255],"category_scores_gemma":[0.00055511843,0.00026483837,0.0004860341,0.0013988501,0.0003642645,0.0010285337,0.00048090148,0.0011570851,0.003842341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008720427,0.000064521046,0.00021654497,0.011418903,0.00009111707,0.0005159358,0.00003486293,0.0002629905,0.0038482018,0.0015621071,0.020538468,0.9613591],"study_design_scores_gemma":[0.000054671957,0.00019171275,0.0018154712,0.002916483,0.00017976422,0.0039418675,0.00006977648,0.00019149987,0.0021758652,0.0019530882,0.9864784,0.000031404954],"about_ca_topic_score_codex":0.0010134982,"about_ca_topic_score_gemma":0.0016409055,"teacher_disagreement_score":0.004011255,"about_ca_system_score_codex":0.0005647565,"about_ca_system_score_gemma":0.00073166273,"threshold_uncertainty_score":0.0134189725},"labels":[],"label_agreement":null},{"id":"W2023792717","doi":"10.1517/17425250902865586","title":"Characterization and expression of extrahepatic CYP2S1","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Context (archaeology); Gene expression; Isozyme; Enzyme; Gene; Biochemistry; Genetics; Biology","score_opus":0.1341981640508461,"score_gpt":0.46143677831385393,"score_spread":0.3272386142630078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023792717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010673494,0.9787445,0.0035781353,0.0006771632,0.00023206491,0.000029675284,0.00037719993,0.000040829364,0.0056468653],"genre_scores_gemma":[0.07138155,0.91154414,0.0045698374,0.0004455424,0.0006156928,0.00006614159,0.0017108419,0.000021793448,0.009644411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981993,0.000031451782,0.000015195054,0.00004949372,0.000066734916,0.00001731554],"domain_scores_gemma":[0.99979526,0.000051678737,0.000038894636,0.000013883712,0.00008860861,0.000011844626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039303323,0.0004803968,0.0006885828,0.0008497038,0.000075303265,0.00041414198,0.0003549806,0.00041245806,0.0018879215],"category_scores_gemma":[0.0003642753,0.00013182183,0.00036492632,0.0008499192,0.00021664401,0.00037004778,0.00016867544,0.00054221257,0.0016832231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003875359,0.00005993999,0.003431013,0.009965615,0.00016476009,0.00080749736,0.000057742323,0.0006775532,0.10971101,0.0023530698,0.011344695,0.8610395],"study_design_scores_gemma":[0.00007665362,0.0005758459,0.020639146,0.001132981,0.0004466478,0.0090977615,0.00006895159,0.0010229156,0.14885426,0.0018344099,0.81619626,0.000054091208],"about_ca_topic_score_codex":0.0007548465,"about_ca_topic_score_gemma":0.00062382274,"teacher_disagreement_score":0.0018879215,"about_ca_system_score_codex":0.0003510465,"about_ca_system_score_gemma":0.00041796252,"threshold_uncertainty_score":0.006315708},"labels":[],"label_agreement":null},{"id":"W2025903076","doi":"10.1517/17425251003601961","title":"Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Phospholipidosis; Monoacylglycerol lipase; Biomarker; Context (archaeology); Drug; Medicine; Toxicogenomics; Pharmacology; Toxicity; Bioinformatics; Internal medicine; Biology; Phospholipid","score_opus":0.03404822831984583,"score_gpt":0.3596235980960768,"score_spread":0.32557536977623097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025903076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081492815,0.99387807,0.0014429566,0.0008134392,0.00044360355,0.000020409383,0.000029758667,0.000015511972,0.0025413844],"genre_scores_gemma":[0.004930781,0.9875803,0.002883788,0.0008326305,0.0004643442,0.00003797256,0.000056310237,0.000006666957,0.0032071024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997242,0.00006072035,0.000038251164,0.00004321329,0.00011763798,0.000015935364],"domain_scores_gemma":[0.99970764,0.00012209741,0.000049906514,0.000009447557,0.0000920273,0.000018828354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066068606,0.00073648256,0.0012350084,0.0015747276,0.00013210306,0.0006606917,0.00062360615,0.0015640343,0.0018471982],"category_scores_gemma":[0.00051759597,0.00019021243,0.00038353924,0.0011110123,0.0004050284,0.0009525424,0.00030616077,0.001170782,0.002610027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026026255,0.00017727252,0.0011657374,0.012179168,0.00014343267,0.001411948,0.00011186154,0.0004893022,0.05002486,0.005137403,0.017305132,0.9115937],"study_design_scores_gemma":[0.000075859985,0.00071803655,0.005903491,0.0036472431,0.00029802017,0.01638043,0.00023720664,0.0006958944,0.034643654,0.0037751524,0.9335488,0.00007629305],"about_ca_topic_score_codex":0.00059413386,"about_ca_topic_score_gemma":0.0010978611,"teacher_disagreement_score":0.0018471982,"about_ca_system_score_codex":0.0005097815,"about_ca_system_score_gemma":0.00054545153,"threshold_uncertainty_score":0.0061795115},"labels":[],"label_agreement":null},{"id":"W2026509945","doi":"10.1517/17425251003781912","title":"Ambient tonicity and intestinal cytochrome CYP3A","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP3A; Tonicity; Biology; Osmotic shock; In vivo; Transcriptome; Enterocyte; In vitro; Cell biology; Gastrointestinal tract; Transcription factor; Gene expression; Endocrinology; Gene; Biochemistry; Small intestine; Genetics","score_opus":0.028372920586573026,"score_gpt":0.3420128389880099,"score_spread":0.31363991840143685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026509945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021791458,0.9979304,0.00011997751,0.0004478538,0.00019120456,0.000003277649,0.000019655003,0.0000058832056,0.0010637864],"genre_scores_gemma":[0.0013731564,0.9965496,0.00015901505,0.00027802598,0.00025801806,0.0000074686764,0.00003446486,0.0000015965368,0.0013385909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998913,0.000017650944,0.000015419979,0.000020623176,0.00004428801,0.000010700388],"domain_scores_gemma":[0.9998702,0.000045016935,0.00002914178,0.00000409089,0.000040357812,0.000011159202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027817042,0.00049181207,0.0009964686,0.000977148,0.00015937854,0.0006188461,0.00050341187,0.00089782296,0.003971651],"category_scores_gemma":[0.00031874803,0.00017766227,0.00034744287,0.0015470122,0.0002700571,0.0010647101,0.00033370545,0.0009124785,0.002529121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014592828,0.000041275507,0.0003915293,0.020204306,0.00012631883,0.00064573943,0.00007734694,0.00026525924,0.008835147,0.002872638,0.03595865,0.9304358],"study_design_scores_gemma":[0.000031779196,0.00012920753,0.0030418797,0.002509898,0.00015238488,0.0035371026,0.00010054116,0.00008147587,0.0017743694,0.0018594398,0.9867575,0.000024333145],"about_ca_topic_score_codex":0.0009166613,"about_ca_topic_score_gemma":0.0018664757,"teacher_disagreement_score":0.003971651,"about_ca_system_score_codex":0.000441461,"about_ca_system_score_gemma":0.0007457194,"threshold_uncertainty_score":0.013286531},"labels":[],"label_agreement":null},{"id":"W2028524821","doi":"10.1517/17425255.2013.832755","title":"The role of afatinib in the management of non-small cell lung carcinoma","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Afatinib; T790M; Medicine; Resistance mutation; Lung cancer; Lapatinib; Tyrosine kinase; Tyrosine-kinase inhibitor; Drug resistance; Targeted therapy; Cancer research; Oncology; Pharmacology; Erlotinib; Epidermal growth factor receptor; Cancer; Internal medicine; Gefitinib; Biology; Receptor; Trastuzumab; Genetics","score_opus":0.02677984578039177,"score_gpt":0.36038117216467985,"score_spread":0.3336013263842881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028524821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001776711,0.9977831,0.00011528052,0.0006218096,0.00019555922,0.000003850435,0.000011545374,0.000005618798,0.0010855452],"genre_scores_gemma":[0.0021296928,0.9964495,0.0001899452,0.00036007923,0.000268772,0.0000054852344,0.000029652274,0.000001548501,0.00056543405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981064,0.000039293038,0.000029217683,0.000030019466,0.00007340171,0.000017483935],"domain_scores_gemma":[0.9998105,0.00007382875,0.000036914076,0.000004668488,0.000057688703,0.000016323167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004488129,0.00047019156,0.0010438184,0.0014668482,0.00022387375,0.00062055717,0.00073890615,0.0009436215,0.0020450095],"category_scores_gemma":[0.0005544389,0.00012531565,0.00045591762,0.0012402678,0.00035443364,0.0008567117,0.00042337168,0.0016329157,0.0014489458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054126744,0.000024174127,0.000109883535,0.0059416876,0.000061365696,0.00031267913,0.00003112206,0.00026345692,0.0008569688,0.0015092745,0.017737564,0.9730977],"study_design_scores_gemma":[0.000051902767,0.00013168213,0.0013482502,0.0034803995,0.00011791693,0.005525614,0.00005988752,0.00020077884,0.00065303524,0.0023105526,0.9860968,0.000023233637],"about_ca_topic_score_codex":0.0006875051,"about_ca_topic_score_gemma":0.0018122767,"teacher_disagreement_score":0.0020450095,"about_ca_system_score_codex":0.0005330937,"about_ca_system_score_gemma":0.0005926625,"threshold_uncertainty_score":0.0068412423},"labels":[],"label_agreement":null},{"id":"W2034656862","doi":"10.1517/17425255.2012.722757","title":"The effects of gastric bypass surgery on drug absorption and pharmacokinetics","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Alberta","funders":"","keywords":"Pharmacokinetics; Medicine; Drug; Gastric bypass surgery; Bioavailability; Obesity; Absorption (acoustics); Pharmacology; Jejunoileal bypass; Overweight; Gastric bypass; Internal medicine; Weight loss; Morbid obesity","score_opus":0.04201938361697426,"score_gpt":0.3446971340951774,"score_spread":0.3026777504782031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034656862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000116842006,0.99940383,0.00002571873,0.000122022364,0.000053123906,0.000002493987,0.000013465713,0.000001772708,0.0002607121],"genre_scores_gemma":[0.001020878,0.9986094,0.000055355362,0.00007905844,0.00006970664,0.0000040208392,0.000013133977,5.2499746e-7,0.00014774188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995938,0.00008285689,0.0000753062,0.00006119514,0.00016216682,0.000024736652],"domain_scores_gemma":[0.9991129,0.00048157026,0.00020178224,0.000011470575,0.00017003926,0.000022160522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059754093,0.0007137226,0.0017266603,0.0015926296,0.00015044442,0.00078782206,0.00051217637,0.00086761755,0.0035804592],"category_scores_gemma":[0.001614497,0.00019613028,0.00077417755,0.0020048097,0.00030048942,0.0008139155,0.000351049,0.000687344,0.0009499766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017684799,0.000045447825,0.00044967738,0.103088215,0.0003823282,0.00029541907,0.00006667801,0.00024532338,0.0014425056,0.0009405317,0.015263347,0.87760365],"study_design_scores_gemma":[0.00011210247,0.00057696906,0.009047036,0.06430249,0.0026944615,0.0060932385,0.00025376657,0.00031559932,0.0024453849,0.0025223843,0.9115651,0.00007143713],"about_ca_topic_score_codex":0.00173889,"about_ca_topic_score_gemma":0.0023812468,"teacher_disagreement_score":0.0035804592,"about_ca_system_score_codex":0.0004638523,"about_ca_system_score_gemma":0.0012656335,"threshold_uncertainty_score":0.011977792},"labels":[],"label_agreement":null},{"id":"W2036183577","doi":"10.1517/17425250903114182","title":"Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Mycophenolic acid; Medicine; MEDLINE; Transplantation; Intensive care medicine; Organ transplantation; Kidney transplantation; Systematic review; Internal medicine","score_opus":0.0876783639433172,"score_gpt":0.418184643719522,"score_spread":0.33050627977620484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036183577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010237822,0.9975903,0.0003717673,0.00024231698,0.00006550146,0.00039686862,0.00010878173,0.00000691076,0.00019379646],"genre_scores_gemma":[0.018805822,0.97714555,0.0025391807,0.00029519506,0.00006210533,0.0009219556,0.00014211606,0.000004189135,0.000083927116],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.984718,0.008168725,0.0042561255,0.0005957666,0.0021076072,0.00015383927],"domain_scores_gemma":[0.9390208,0.047471847,0.008842517,0.0005445278,0.003759966,0.0003604211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017366044,0.0014946372,0.008302651,0.008689468,0.0005074015,0.001929022,0.0019714797,0.0015192826,0.0033363963],"category_scores_gemma":[0.07353751,0.0010058384,0.005204149,0.010488448,0.0008456023,0.0025596824,0.0010076056,0.0007568135,0.000309874],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003219078,0.000028189377,0.0016489556,0.8669637,0.008125773,0.00017565097,0.00021452435,0.00022759123,0.00011519845,0.00025021195,0.0014973409,0.12043104],"study_design_scores_gemma":[0.0010201928,0.0006707166,0.008053728,0.87991434,0.086927116,0.00086495985,0.0005680302,0.0004884495,0.00043165125,0.00063664257,0.020342052,0.00008205598],"about_ca_topic_score_codex":0.006102332,"about_ca_topic_score_gemma":0.015731962,"teacher_disagreement_score":0.017366044,"about_ca_system_score_codex":0.0033822914,"about_ca_system_score_gemma":0.010516188,"threshold_uncertainty_score":0.09184146},"labels":[],"label_agreement":null},{"id":"W2040137868","doi":"10.1517/17425250902873804","title":"Rosiglitazone in Canada: experience in clinical practice","year":2009,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); University of Toronto; Diabetes Canada; University of Ottawa","funders":"","keywords":"Rosiglitazone; Medicine; Sulfonylurea; Metformin; Type 2 diabetes; Observational study; Diabetes mellitus; Family medicine; Clinical Practice; Clinical trial; Type 2 Diabetes Mellitus; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.04013011643806443,"score_gpt":0.3764027745857627,"score_spread":0.3362726581476983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040137868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84818876,0.076913446,0.0012721949,0.033129234,0.00065557973,0.000714243,0.001568404,0.00018710356,0.03737099],"genre_scores_gemma":[0.9209007,0.05948753,0.003490654,0.007485312,0.00040478838,0.00012561565,0.0010906702,0.00007627066,0.0069383844],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99815804,0.0002630177,0.00011073231,0.00023590517,0.0009222137,0.00031013024],"domain_scores_gemma":[0.9921934,0.0005925351,0.00083421305,0.00016544448,0.0025394976,0.0036749842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505694,0.00033074216,0.0003335181,0.0006882761,0.0022589173,0.0020293603,0.0009277725,0.00092985126,0.0035111995],"category_scores_gemma":[0.005645516,0.00018619577,0.00023591077,0.0028239444,0.001034279,0.0005504411,0.00092187576,0.0011403745,0.00044547842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019821683,0.0023154984,0.32208115,0.0010278393,0.00014092447,0.0058989883,0.011840515,0.0006068747,0.0031356863,0.0022849173,0.038767688,0.6099177],"study_design_scores_gemma":[0.001219566,0.0030120767,0.6526078,0.0023281474,0.00033603472,0.010570434,0.020929476,0.0017940056,0.0024093213,0.0010037665,0.30354536,0.00024403255],"about_ca_topic_score_codex":0.7692793,"about_ca_topic_score_gemma":0.82849395,"teacher_disagreement_score":0.2307207,"about_ca_system_score_codex":0.019417422,"about_ca_system_score_gemma":0.053241555,"threshold_uncertainty_score":0.4641589},"labels":[],"label_agreement":null},{"id":"W2045537064","doi":"10.1517/17425250903234709","title":"Glucocorticoids and phenobarbital induce murine<i>CYP2B</i>genes by independent mechanisms","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Phenobarbital; Biology; Gene; Glucocorticoid; Inducer; Glucocorticoid receptor; Nuclear receptor; Cell biology; Transcription factor; Genetics; Pharmacology; Immunology","score_opus":0.10458827221336382,"score_gpt":0.4432972763190783,"score_spread":0.3387090041057145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045537064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001951306,0.98791724,0.0017935698,0.000685424,0.00039381132,0.000024103421,0.00014310575,0.00007086417,0.007020546],"genre_scores_gemma":[0.007439738,0.98685724,0.0010420013,0.00051154254,0.00027074086,0.000030193862,0.00020306658,0.000007941315,0.0036374552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987745,0.00002207514,0.00001265999,0.000029915213,0.00004501439,0.00001282872],"domain_scores_gemma":[0.99990594,0.00002554675,0.000027006145,0.0000053853664,0.000027372318,0.000008627569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018154114,0.00060920883,0.00067498937,0.0004704231,0.00007663951,0.00034339348,0.00036795947,0.0005400229,0.0029953297],"category_scores_gemma":[0.00015073619,0.00013962795,0.00032288686,0.00059852534,0.00019686697,0.00037617373,0.0001959828,0.0005533775,0.0036150825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014241853,0.000044694134,0.00044979792,0.009830034,0.00007709415,0.0003943809,0.000035529843,0.00033599048,0.072434,0.0030198281,0.019392127,0.8938441],"study_design_scores_gemma":[0.000049936196,0.00024364231,0.0030787443,0.0009788731,0.00011003385,0.0025507433,0.00004375179,0.00012438871,0.028362438,0.0015457368,0.9628889,0.00002282211],"about_ca_topic_score_codex":0.0004811436,"about_ca_topic_score_gemma":0.0008389254,"teacher_disagreement_score":0.0029953297,"about_ca_system_score_codex":0.00027652358,"about_ca_system_score_gemma":0.00029896776,"threshold_uncertainty_score":0.010020435},"labels":[],"label_agreement":null},{"id":"W2058230408","doi":"10.1517/17425255.2013.754423","title":"Improving the prediction of drug disposition in the brain","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"","keywords":"ADME; Computer science; Disposition; Risk analysis (engineering); Drug discovery; Biochemical engineering; Drug; Expert opinion; Bioinformatics; Medicine; Pharmacology; Intensive care medicine; Engineering; Biology; Psychology","score_opus":0.04935277556080994,"score_gpt":0.3570767268730604,"score_spread":0.3077239513122505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058230408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010149253,0.86469424,0.1135526,0.0041616433,0.0007736261,0.000065704524,0.0006911852,0.00054544647,0.005366338],"genre_scores_gemma":[0.084134914,0.86662537,0.042400327,0.00089552754,0.0009195615,0.000089810186,0.0011853848,0.00008718277,0.0036619746],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99971837,0.00007686509,0.000017536926,0.000061529674,0.0001103494,0.000015378839],"domain_scores_gemma":[0.99905866,0.0005659865,0.00010779983,0.000025025887,0.00021977934,0.000022863276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093776576,0.0008720293,0.0012717963,0.0011433674,0.0000967419,0.00095490273,0.0010100295,0.0009481117,0.0021144454],"category_scores_gemma":[0.0024899277,0.000251228,0.00093421055,0.001098975,0.00027167343,0.0007802578,0.0003776426,0.0009770478,0.0015515648],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009111131,0.00007118958,0.0024160508,0.003672408,0.000370621,0.000094496325,0.000017889557,0.037036374,0.0022362173,0.0045652646,0.01505893,0.93436944],"study_design_scores_gemma":[0.00014783618,0.00085533404,0.01361579,0.0059623034,0.0013428174,0.002352869,0.00009312022,0.55924463,0.0167578,0.043321375,0.35606956,0.00023647079],"about_ca_topic_score_codex":0.0023781396,"about_ca_topic_score_gemma":0.0018010795,"teacher_disagreement_score":0.0023781396,"about_ca_system_score_codex":0.00038563434,"about_ca_system_score_gemma":0.00069615705,"threshold_uncertainty_score":0.0070735216},"labels":[],"label_agreement":null},{"id":"W2062437098","doi":"10.1517/17425255.2012.730518","title":"Is there a role for tirapazamine in the treatment of cervical cancer?","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services","funders":"","keywords":"Tirapazamine; Medicine; Cervical cancer; Oncology; Clinical trial; Radiation therapy; Chemotherapy; Cancer; Malignancy; Internal medicine; Surgery; Biology","score_opus":0.0548692678472238,"score_gpt":0.37067259306644984,"score_spread":0.31580332521922605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062437098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048325717,0.95683205,0.00016059319,0.03738912,0.0033514907,0.000029813864,0.00016016555,0.000014998587,0.0015785159],"genre_scores_gemma":[0.0061361613,0.964217,0.00050899654,0.021606395,0.006042697,0.00005948383,0.00013411512,0.000009550537,0.0012854857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992384,0.0002485175,0.00015599046,0.000101019,0.00020945979,0.00004670231],"domain_scores_gemma":[0.99562883,0.0020317915,0.0011626927,0.000049247818,0.0010013082,0.00012623008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018124008,0.00037099494,0.001795438,0.0006933371,0.00028521405,0.001612143,0.001189199,0.0035439194,0.008663814],"category_scores_gemma":[0.008972496,0.00016117531,0.0014417068,0.0008283589,0.00076669594,0.0021536006,0.00040156025,0.0020513097,0.0025684994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012645965,0.00006316955,0.00071395066,0.105994426,0.0006983765,0.00051588815,0.00015000944,0.00017541459,0.0018434318,0.0029350542,0.17921166,0.706434],"study_design_scores_gemma":[0.0006351864,0.00071644346,0.0022451968,0.08592322,0.0021768138,0.0018466865,0.00048456556,0.00019338919,0.0010190088,0.004585802,0.90009856,0.00007517792],"about_ca_topic_score_codex":0.0015849703,"about_ca_topic_score_gemma":0.0035030788,"teacher_disagreement_score":0.008663814,"about_ca_system_score_codex":0.0011233087,"about_ca_system_score_gemma":0.0025524793,"threshold_uncertainty_score":0.028983295},"labels":[],"label_agreement":null},{"id":"W2062589870","doi":"10.1517/17425250902942302","title":"Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Adverse effect; Medicine; Intensive care medicine; Concomitant; Regimen; Drug resistance; Drug; Disease; Antiretroviral therapy; Population; Pharmacology; Human immunodeficiency virus (HIV); Immunology; Internal medicine; Viral load; Biology; Environmental health","score_opus":0.023407324063850637,"score_gpt":0.3440731979562234,"score_spread":0.3206658738923727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062589870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032131994,0.9970847,0.00017123928,0.00030817575,0.00009122812,0.0000072038415,0.000017432043,0.0000057111774,0.0019929314],"genre_scores_gemma":[0.0021630118,0.9956909,0.0003820527,0.00027641462,0.00017167868,0.000011002666,0.000030373452,0.0000013429017,0.001273217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956805,0.00010099625,0.000057014306,0.00005525589,0.00019413141,0.000024642515],"domain_scores_gemma":[0.9995442,0.0002110579,0.00011896113,0.000012909494,0.00009384395,0.000018999468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006267375,0.00071234076,0.001778731,0.0017998642,0.00021616492,0.0009133496,0.00085619435,0.0015819999,0.004985906],"category_scores_gemma":[0.0007768746,0.00023849237,0.0005258246,0.001586629,0.00040567876,0.0008997683,0.0003896854,0.0008972496,0.0028754252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007899793,0.000089168076,0.0005588013,0.015477382,0.00012699085,0.0008678763,0.00006155517,0.00033679567,0.003588291,0.0017148737,0.015083774,0.9620154],"study_design_scores_gemma":[0.000052478317,0.00033134883,0.0036490455,0.0060517117,0.00025553448,0.0116650965,0.00017178858,0.00023243038,0.003057901,0.0023462928,0.9721481,0.000038294234],"about_ca_topic_score_codex":0.0009996117,"about_ca_topic_score_gemma":0.0019469089,"teacher_disagreement_score":0.004985906,"about_ca_system_score_codex":0.00044471916,"about_ca_system_score_gemma":0.00090563286,"threshold_uncertainty_score":0.016679466},"labels":[],"label_agreement":null},{"id":"W2078673527","doi":"10.1517/17425255.2012.680884","title":"Pharmacokinetic and pharmacogenetic determinants and considerations in chemotherapy selection and dosing in infants","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Dosing; Medicine; Chemotherapy; Pharmacokinetics; Pharmacogenetics; Intensive care medicine; Adverse effect; Pharmacology; Internal medicine; Biology","score_opus":0.05969561980625835,"score_gpt":0.4116720124127099,"score_spread":0.3519763926064515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078673527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043224354,0.99734676,0.00039975668,0.0011314994,0.00007272706,0.0000075395064,0.000028860512,0.0000042616334,0.0005763623],"genre_scores_gemma":[0.0045907167,0.99384576,0.0006874015,0.0003975223,0.00020361257,0.000015969428,0.00004486201,0.0000019862687,0.0002120942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999116,0.00041718292,0.00012568008,0.00010138532,0.00020635416,0.000033334123],"domain_scores_gemma":[0.99751496,0.0016883087,0.00048908725,0.000031012332,0.00023598554,0.000040542753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018493473,0.00045075387,0.0014712947,0.00084077317,0.00011886875,0.0008410938,0.00065418513,0.00087127765,0.0017607597],"category_scores_gemma":[0.0052143396,0.0001921826,0.0007440587,0.001151206,0.00041823095,0.0007624835,0.00035967474,0.0013369801,0.00058776536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025267724,0.00005126126,0.0035266513,0.015655259,0.00032795803,0.00049500115,0.00008552352,0.0009637233,0.00082207756,0.003933859,0.014925456,0.95896065],"study_design_scores_gemma":[0.00018955886,0.0006325415,0.023663985,0.03476006,0.0019170117,0.013025116,0.00028245588,0.0015283392,0.0031080628,0.010713458,0.9100854,0.000094007286],"about_ca_topic_score_codex":0.0015778051,"about_ca_topic_score_gemma":0.0017594444,"teacher_disagreement_score":0.0018493473,"about_ca_system_score_codex":0.0006430388,"about_ca_system_score_gemma":0.00146798,"threshold_uncertainty_score":0.009780407},"labels":[],"label_agreement":null},{"id":"W2093023603","doi":"10.1517/17425255.2.4.533","title":"Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Opioid; Drug; Human immunodeficiency virus (HIV); Seroconversion; Antiretroviral therapy; Pharmacology; Intensive care medicine; Viral load; Internal medicine; Immunology","score_opus":0.10033650623971041,"score_gpt":0.4246921019417489,"score_spread":0.3243555957020385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093023603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021270143,0.99840647,0.0001244567,0.00016413236,0.00008806695,0.000008367711,0.00001581048,0.0000030754863,0.0009769142],"genre_scores_gemma":[0.0015788578,0.9973876,0.00025599118,0.0001556637,0.000110030625,0.000011926382,0.00002171909,7.326209e-7,0.00047753003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950457,0.00016494119,0.00007560125,0.000047684756,0.0001834139,0.000023807104],"domain_scores_gemma":[0.99954236,0.00024715372,0.00009787193,0.000011383791,0.00008792373,0.000013421536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006312317,0.00059478596,0.0015784242,0.0011879688,0.00016524292,0.00066641136,0.0007528989,0.0008725384,0.0038458486],"category_scores_gemma":[0.0009851978,0.00017845718,0.00063109904,0.0013701414,0.00019413761,0.00066384126,0.00034640386,0.00062930316,0.0015246397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121402394,0.0000843418,0.00034108723,0.029456556,0.00028813182,0.00057845697,0.00006313085,0.00031046395,0.0024147402,0.0009606771,0.0129975695,0.9523834],"study_design_scores_gemma":[0.00011370831,0.00060557167,0.0040081744,0.014254026,0.00079660694,0.007757252,0.00014780306,0.00022540822,0.0021616644,0.0016908423,0.9682049,0.000033956854],"about_ca_topic_score_codex":0.00084223616,"about_ca_topic_score_gemma":0.0017669491,"teacher_disagreement_score":0.0038458486,"about_ca_system_score_codex":0.00033738965,"about_ca_system_score_gemma":0.0007949235,"threshold_uncertainty_score":0.012865603},"labels":[],"label_agreement":null},{"id":"W2094887438","doi":"10.1517/17425250902918302","title":"Regulation of CYP1A1 by heavy metals and consequences for drug metabolism","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Aryl hydrocarbon receptor; Cytochrome P450; Drug metabolism; Chemistry; Carcinogen; Prodrug; Metabolism; Enzyme; Drug; Metabolic pathway; Pharmacology; Biochemistry; Biology; Transcription factor","score_opus":0.03998431245104483,"score_gpt":0.35093408886910765,"score_spread":0.3109497764180628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094887438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005333349,0.99585706,0.00033963396,0.00047980482,0.00026766173,0.0000068954314,0.0000330253,0.000014020969,0.0024685145],"genre_scores_gemma":[0.0018229629,0.9951456,0.00033655384,0.00025607596,0.00021180566,0.000009417836,0.000057319303,0.0000019683614,0.0021583522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983335,0.000026582937,0.000015891603,0.00003438887,0.000074017116,0.000015730117],"domain_scores_gemma":[0.9998846,0.000036282065,0.00002160971,0.0000053599815,0.000041480016,0.000010677982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030095904,0.0006407101,0.0011521999,0.0009332395,0.00018037851,0.0005576297,0.0007171975,0.00091262243,0.003993122],"category_scores_gemma":[0.00030329335,0.0001957678,0.00039027038,0.0013497897,0.00022687415,0.00067090464,0.00037173202,0.00080235454,0.0035574601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008715437,0.00006152002,0.00019104773,0.010349807,0.00008263894,0.0004020215,0.000044853725,0.00040306227,0.008136151,0.0024462296,0.027471876,0.9503236],"study_design_scores_gemma":[0.00003466219,0.00012609252,0.0011291257,0.0011680786,0.0000858761,0.0021869813,0.000045017943,0.00016173717,0.0026620864,0.0019811322,0.99040014,0.000019029827],"about_ca_topic_score_codex":0.00080618693,"about_ca_topic_score_gemma":0.0014347873,"teacher_disagreement_score":0.003993122,"about_ca_system_score_codex":0.00053981575,"about_ca_system_score_gemma":0.00059480383,"threshold_uncertainty_score":0.013358355},"labels":[],"label_agreement":null},{"id":"W2101952653","doi":"10.1517/17425255.2.6.1019","title":"Glatiramer acetate therapy for multiple sclerosis: a review","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Medicine; Tolerability; Neuroprotection; Clinical trial; Drug; Clinically isolated syndrome; Disease; Pharmacology; Immunology; Oncology; Internal medicine; Adverse effect","score_opus":0.20941971867318362,"score_gpt":0.43408029628116246,"score_spread":0.22466057760797883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101952653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009471456,0.9993155,0.000044788147,0.00011465852,0.000104369006,0.0000054538314,0.000011802721,0.0000046779624,0.00030402862],"genre_scores_gemma":[0.0006546086,0.9985613,0.00012814737,0.00023723979,0.00017673514,0.00001256239,0.000030145668,0.0000015424581,0.0001975892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997981,0.00004300635,0.000050178347,0.000039510487,0.000054490632,0.000014699672],"domain_scores_gemma":[0.99959177,0.00023205078,0.00007281197,0.000009375927,0.00006495341,0.000029108254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006191744,0.00086078135,0.001633163,0.0023131082,0.00029284638,0.00095158274,0.0012984538,0.0011403967,0.0036009843],"category_scores_gemma":[0.0008314624,0.00025023328,0.0008513972,0.0021727826,0.00043929883,0.0011665896,0.00049128826,0.0015407072,0.001591911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014860986,0.000106292806,0.00014390663,0.031244675,0.00018657387,0.00022147324,0.000056330253,0.000230506,0.00068253896,0.000963855,0.024923386,0.9410918],"study_design_scores_gemma":[0.0001362975,0.00051224313,0.001985564,0.020831415,0.00079845835,0.003947218,0.00009240936,0.00017971224,0.0004683657,0.0011969437,0.9698117,0.000039699687],"about_ca_topic_score_codex":0.0010420514,"about_ca_topic_score_gemma":0.0016750913,"teacher_disagreement_score":0.0036009843,"about_ca_system_score_codex":0.00048752126,"about_ca_system_score_gemma":0.00062181405,"threshold_uncertainty_score":0.012046516},"labels":[],"label_agreement":null},{"id":"W2103392332","doi":"10.1517/17425255.2015.985649","title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug; Medicine; Pharmacology; Intensive care medicine","score_opus":0.051630284045554566,"score_gpt":0.3383198970766768,"score_spread":0.2866896130311222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103392332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013145774,0.9969146,0.0003040868,0.00079057,0.00025684378,0.000006244063,0.000026537611,0.000014133146,0.0015554989],"genre_scores_gemma":[0.0007492399,0.9977361,0.00024384263,0.000338014,0.0002156993,0.000007758539,0.000036259393,0.0000016352984,0.0006714859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998173,0.000029237139,0.00002131667,0.000033997145,0.00007781075,0.000020265961],"domain_scores_gemma":[0.99967134,0.0001295142,0.00005917176,0.000009567258,0.00010084998,0.000029569675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005159102,0.000697323,0.0010383921,0.0011148858,0.00024066467,0.000958154,0.00074429065,0.0011648978,0.004558398],"category_scores_gemma":[0.0006503056,0.00019107078,0.0005231151,0.001140909,0.0004369021,0.0013304935,0.0005300981,0.0017259999,0.0027223183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006243392,0.0000398529,0.00016994201,0.014780937,0.00007043407,0.00023725591,0.00005258567,0.00036173032,0.0022476837,0.0047997087,0.038671795,0.9385056],"study_design_scores_gemma":[0.00001552106,0.00007211891,0.0006284975,0.0040110145,0.00009668698,0.0017678568,0.00005988832,0.00012743186,0.00061473134,0.004045827,0.98854303,0.000017397573],"about_ca_topic_score_codex":0.0007914161,"about_ca_topic_score_gemma":0.001070386,"teacher_disagreement_score":0.004558398,"about_ca_system_score_codex":0.00059514574,"about_ca_system_score_gemma":0.0010309618,"threshold_uncertainty_score":0.015249312},"labels":[],"label_agreement":null},{"id":"W2105874372","doi":"10.1517/17425250902800153","title":"Ethnic differences in drug metabolism and toxicity from chemotherapy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacokinetics; Irinotecan; Drug; Pharmacology; Drug metabolism; Toxicity; Pharmacogenetics; Paclitaxel; Medicine; Pharmacodynamics; Biology; Chemotherapy; Cancer; Internal medicine; Genetics; Genotype; Gene","score_opus":0.1774474249782567,"score_gpt":0.4679789391038559,"score_spread":0.2905315141255992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105874372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026309775,0.9963987,0.00022158222,0.00073833874,0.00020019087,0.00000951615,0.000049633716,0.000008407269,0.0021105558],"genre_scores_gemma":[0.0015581589,0.99654824,0.00017586153,0.00037578426,0.00019827478,0.000011920835,0.00007922233,0.0000018283633,0.0010507451],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995968,0.0000965995,0.00004625688,0.000071551396,0.00015916044,0.00002962256],"domain_scores_gemma":[0.99965036,0.00014617607,0.00008127446,0.00001053508,0.00009234943,0.000019302042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081183534,0.0007018573,0.0022520476,0.0009246534,0.00016287612,0.00082708825,0.0010555228,0.0010924393,0.005924247],"category_scores_gemma":[0.0009694684,0.00020804213,0.0007720653,0.0013760908,0.0003022795,0.0006963866,0.0005012648,0.0009953751,0.00322738],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098245044,0.00003790712,0.00049887144,0.01125598,0.00020658164,0.00038302204,0.00003793041,0.0003620816,0.0011701905,0.0014896677,0.02862348,0.9558359],"study_design_scores_gemma":[0.00008318699,0.00019486377,0.0050635845,0.0059418906,0.00037552862,0.0049879346,0.00008273902,0.00022278455,0.0009289155,0.0031997408,0.9788841,0.000034726676],"about_ca_topic_score_codex":0.0014840566,"about_ca_topic_score_gemma":0.002891784,"teacher_disagreement_score":0.005924247,"about_ca_system_score_codex":0.00071609725,"about_ca_system_score_gemma":0.00090077234,"threshold_uncertainty_score":0.019818604},"labels":[],"label_agreement":null},{"id":"W2106387716","doi":"10.1517/17425250802560279","title":"Pharmacogenetics and the serotonin transporter in late-life depression","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Serotonin transporter; Antidepressant; Depression (economics); Pharmacogenetics; Paroxetine; Serotonin; Medicine; Psychology; 5-HTTLPR; Psychiatry; Genotype; Internal medicine; Genetics; Biology; Gene; Anxiety; Receptor","score_opus":0.07519045788432875,"score_gpt":0.3714474857813355,"score_spread":0.29625702789700675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106387716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064343825,0.92970693,0.00037618453,0.0022613052,0.00008186726,0.000036820813,0.000917096,0.0000074800805,0.002268549],"genre_scores_gemma":[0.4598191,0.5355217,0.0010610505,0.0015626566,0.00035283453,0.000053550724,0.0008494104,0.000004615782,0.00077504874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993019,0.00031450676,0.00018308892,0.00006240727,0.00011285978,0.000025208661],"domain_scores_gemma":[0.9960995,0.002739477,0.0009407752,0.000031390948,0.00015485952,0.00003402477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010384921,0.00013535781,0.0006989894,0.0019783785,0.000105454914,0.0005149389,0.00028681167,0.00071801885,0.0021002186],"category_scores_gemma":[0.0040095923,0.0000964031,0.0005499953,0.0051825955,0.0002576023,0.0004382137,0.0001820761,0.0002937028,0.00019524028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022257573,0.0001623255,0.35458773,0.14103213,0.00550087,0.008664468,0.0014479255,0.0019206067,0.008206245,0.0049252636,0.0104102595,0.46091643],"study_design_scores_gemma":[0.00030389085,0.0006147155,0.89905566,0.032382116,0.008029894,0.011629158,0.0006530842,0.0010270627,0.0010330538,0.0036648873,0.041558813,0.000047646718],"about_ca_topic_score_codex":0.0040685376,"about_ca_topic_score_gemma":0.007568773,"teacher_disagreement_score":0.0040685376,"about_ca_system_score_codex":0.00044861762,"about_ca_system_score_gemma":0.000703382,"threshold_uncertainty_score":0.008089662},"labels":[],"label_agreement":null},{"id":"W2109535341","doi":"10.1517/17425255.2012.712684","title":"Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Esomeprazole; Medicine; Aspirin; Proton-pump inhibitor; Pharmacokinetics; Adverse effect; Internal medicine; Primary prevention; Lansoprazole; Incidence (geometry); Intensive care medicine; Gastroenterology; Omeprazole; Disease","score_opus":0.09234133826754146,"score_gpt":0.4225028711945722,"score_spread":0.33016153292703077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109535341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015523173,0.9735421,0.0011366602,0.003853647,0.00049621874,0.00009489026,0.00037980868,0.000024948698,0.0049485164],"genre_scores_gemma":[0.17663762,0.8121715,0.002694975,0.0031220098,0.0018183138,0.00017042857,0.0006797939,0.00001672756,0.0026885804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990361,0.00037900868,0.000114560346,0.00010694219,0.00032478257,0.00003866841],"domain_scores_gemma":[0.99804556,0.0007690516,0.0005883626,0.00003372043,0.0004888352,0.00007439612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015193173,0.00028218844,0.0009983877,0.00040966313,0.00011649923,0.00068902393,0.00038858142,0.0008129404,0.0033862668],"category_scores_gemma":[0.0037497415,0.00009134554,0.00079659635,0.0005231747,0.0001743233,0.0003903236,0.00018999475,0.00076923065,0.0005673465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043448,0.00038631898,0.014994693,0.02426903,0.0017115251,0.00084749673,0.000154708,0.00080215425,0.008906504,0.0015079122,0.028816681,0.9132581],"study_design_scores_gemma":[0.0031671464,0.020452207,0.19861549,0.02875437,0.013200705,0.014160121,0.00053002045,0.00568385,0.018506326,0.005581354,0.69110674,0.0002416878],"about_ca_topic_score_codex":0.00055813725,"about_ca_topic_score_gemma":0.001259972,"teacher_disagreement_score":0.0033862668,"about_ca_system_score_codex":0.00032968377,"about_ca_system_score_gemma":0.00067675003,"threshold_uncertainty_score":0.011328161},"labels":[],"label_agreement":null},{"id":"W2118799685","doi":"10.1517/17425255.3.6.819","title":"Drug transport across the placenta, role of the ABC drug efflux transporters","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transplacental; Placenta; Fetus; Drug; Xenobiotic; ATP-binding cassette transporter; Pharmacology; Efflux; P-glycoprotein; Pregnancy; Transporter; Medicine; Biology; Physiology; Drug resistance; Biochemistry; Multiple drug resistance; Genetics","score_opus":0.02846913230624061,"score_gpt":0.3453185441175208,"score_spread":0.3168494118112802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118799685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013913843,0.9974987,0.00017555329,0.0007459777,0.00020341945,0.0000038710277,0.000012925065,0.0000055998016,0.0012148746],"genre_scores_gemma":[0.0006885946,0.9977054,0.00025604977,0.00029610688,0.0002056588,0.000006136383,0.000020305597,8.2809663e-7,0.00082089537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976164,0.000052599935,0.000023893937,0.000037315487,0.00010369881,0.000020884236],"domain_scores_gemma":[0.99973124,0.0000831996,0.000047248635,0.0000082982115,0.00010604748,0.000023994138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006139793,0.000755542,0.0018067945,0.0012750463,0.00024029208,0.0010911443,0.000919686,0.001437071,0.0039888346],"category_scores_gemma":[0.0005275921,0.00024055869,0.0004578376,0.0014785877,0.00039320806,0.0013323145,0.00038669768,0.001273138,0.003596474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008066189,0.00006738571,0.00021725461,0.013177857,0.00008637112,0.00069707097,0.000055795437,0.00039509503,0.0050574695,0.0033997355,0.03883273,0.93793255],"study_design_scores_gemma":[0.000036318273,0.0001233514,0.0008907844,0.002114336,0.00008891213,0.0032592628,0.00007680553,0.0001723424,0.0011551806,0.0024913715,0.9895699,0.000021499873],"about_ca_topic_score_codex":0.0011106223,"about_ca_topic_score_gemma":0.0022917946,"teacher_disagreement_score":0.0039888346,"about_ca_system_score_codex":0.0007493136,"about_ca_system_score_gemma":0.001090792,"threshold_uncertainty_score":0.01334399},"labels":[],"label_agreement":null},{"id":"W2122533917","doi":"10.1517/17425250902976862","title":"Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancerföreningen i Stockholm; World Anti-Doping Agency","keywords":"Testosterone (patch); Androgen; Androgen deficiency; Medicine; Anabolic-Androgenic Steroids; Testosterone replacement; Substance abuse; Anabolism; Endocrinology; Internal medicine; Hormone; Psychiatry","score_opus":0.11427054977465828,"score_gpt":0.43765213595443053,"score_spread":0.32338158617977225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122533917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020861623,0.9972729,0.00018831255,0.0014494107,0.00018496708,0.0000025223408,0.0000117441505,0.0000034967575,0.00067806785],"genre_scores_gemma":[0.002205855,0.9962734,0.00029101307,0.00049714255,0.00036106067,0.000005546986,0.0000148671725,9.554795e-7,0.0003501426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996253,0.00014287581,0.000046325436,0.000059025097,0.00010744897,0.000018952038],"domain_scores_gemma":[0.9992512,0.0005077655,0.00008436376,0.000013565759,0.00011310921,0.000029983104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097482087,0.0005842452,0.0019431452,0.0010066907,0.00021427192,0.00067258324,0.000737404,0.0013290099,0.0032119513],"category_scores_gemma":[0.0014656731,0.00016026777,0.00047634714,0.0014950631,0.00058551953,0.00074804295,0.0003603294,0.0009673486,0.001168473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008508235,0.000071532515,0.0017926636,0.010421417,0.00022546116,0.0015560368,0.00011914668,0.0003485209,0.0012220817,0.0030728423,0.02582944,0.95525575],"study_design_scores_gemma":[0.00010720418,0.00033961362,0.01733301,0.017396884,0.0006734643,0.018062437,0.0005631563,0.00042707322,0.0010762638,0.01638448,0.9275432,0.00009321418],"about_ca_topic_score_codex":0.0015808255,"about_ca_topic_score_gemma":0.0026448898,"teacher_disagreement_score":0.0032119513,"about_ca_system_score_codex":0.0005420439,"about_ca_system_score_gemma":0.0010966,"threshold_uncertainty_score":0.0107450485},"labels":[],"label_agreement":null},{"id":"W2124895931","doi":"10.1517/17425250903307455","title":"Raltitrexed: optimism and reality","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health; Island Health","funders":"","keywords":"Raltitrexed; Medicine; Internal medicine; Oncology; Colorectal cancer; Pharmacology; Gastroenterology; Oxaliplatin; Cancer","score_opus":0.07881090996430605,"score_gpt":0.408574688909924,"score_spread":0.3297637789456179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124895931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007721675,0.5033792,0.0010522599,0.47837976,0.010162237,0.000013634525,0.000095099356,0.000038726746,0.0061069825],"genre_scores_gemma":[0.023993349,0.6241483,0.0022937013,0.29899946,0.04520766,0.00008153799,0.00022111583,0.000055240907,0.004999604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686664,0.0013462345,0.0002997725,0.00032787144,0.0009106784,0.00024878266],"domain_scores_gemma":[0.9884912,0.006839187,0.0007208443,0.00028638553,0.0027204019,0.00094203494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0088202795,0.0005560062,0.0012921214,0.000505498,0.00058926584,0.0032875845,0.0015563879,0.0061338404,0.00432416],"category_scores_gemma":[0.013315052,0.00024312573,0.0008728111,0.00048589424,0.00396969,0.006050911,0.0011894153,0.011513364,0.0033515191],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073026976,0.000113618466,0.0006629338,0.0056758923,0.00020232622,0.00094895344,0.0004976128,0.0008740568,0.0019454733,0.044207934,0.5132701,0.43087074],"study_design_scores_gemma":[0.00011851275,0.0002715248,0.0004595734,0.0028157183,0.0000655369,0.0011858891,0.00050941575,0.00027382225,0.00036088846,0.03970816,0.954186,0.00004504633],"about_ca_topic_score_codex":0.0009614721,"about_ca_topic_score_gemma":0.0017764516,"teacher_disagreement_score":0.0088202795,"about_ca_system_score_codex":0.0020504761,"about_ca_system_score_gemma":0.0033661583,"threshold_uncertainty_score":0.046646655},"labels":[],"label_agreement":null},{"id":"W2133001403","doi":"10.1517/17425255.2013.772579","title":"Drug interactions between antiretrovirals and hormonal contraceptives","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Efavirenz; Nevirapine; Cobicistat; Pharmacology; Pharmacokinetics; Norethisterone; Drug; Population; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load; Virology; Health services","score_opus":0.07662813474428866,"score_gpt":0.40840799636190195,"score_spread":0.3317798616176133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133001403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111067784,0.9978192,0.000091325805,0.00031447527,0.00015165075,0.0000071116024,0.00003194475,0.000005485472,0.0014677148],"genre_scores_gemma":[0.0013733008,0.9967899,0.0001744687,0.00037068833,0.00026717328,0.000010043637,0.000052092666,0.0000015573279,0.0009606821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994295,0.00012956193,0.00008042826,0.00007720722,0.0002479594,0.000035275305],"domain_scores_gemma":[0.99935263,0.0003162365,0.00016394937,0.00001401859,0.0001303604,0.00002289949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004486277,0.0007630395,0.0015100943,0.0014766571,0.0002528792,0.0008724249,0.0006997308,0.0011962599,0.0076623354],"category_scores_gemma":[0.0010841266,0.00019198113,0.0007005328,0.0018511879,0.00032916808,0.00068995205,0.00042791993,0.0010098799,0.0024088991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059041402,0.000037958198,0.0003413613,0.025835028,0.00020209275,0.00050483504,0.000042350803,0.00026066543,0.001081094,0.0014396588,0.040213164,0.92998284],"study_design_scores_gemma":[0.00003302633,0.000088391214,0.0016294102,0.010836154,0.00035611572,0.005750586,0.000057338446,0.00012565358,0.0006933008,0.0012993871,0.9791084,0.00002223941],"about_ca_topic_score_codex":0.0016292095,"about_ca_topic_score_gemma":0.002761479,"teacher_disagreement_score":0.0076623354,"about_ca_system_score_codex":0.0004972706,"about_ca_system_score_gemma":0.0010248823,"threshold_uncertainty_score":0.025633037},"labels":[],"label_agreement":null},{"id":"W2134794720","doi":"10.1517/17425255.4.9.1143","title":"Whole body physiologically-based pharmacokinetic models: their use in clinical drug development","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Drug development; Pharmacokinetics; Drug; Pharmacology; Physiologically based pharmacokinetic modelling; Medicine; Intensive care medicine","score_opus":0.3293432199936731,"score_gpt":0.49376141390974265,"score_spread":0.16441819391606954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134794720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006366677,0.93619955,0.053118404,0.0023508829,0.00068495737,0.000071181144,0.00014475064,0.00019426919,0.0065993755],"genre_scores_gemma":[0.009509539,0.9610778,0.025599925,0.0008198842,0.00054534705,0.00012483886,0.0001600531,0.00004046077,0.0021222043],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99896014,0.00037808422,0.00007701628,0.00011898815,0.000437929,0.000027851926],"domain_scores_gemma":[0.9983923,0.0009902031,0.0001832208,0.00008485924,0.0003067572,0.000042770203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022905925,0.0011958663,0.0019967393,0.0014961909,0.00020934986,0.0016350105,0.001954078,0.0023771657,0.0028675813],"category_scores_gemma":[0.00357452,0.0005266472,0.0010185868,0.001731805,0.0008402054,0.001875965,0.0007328343,0.0022669348,0.0032153563],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006727778,0.00007141066,0.0003797802,0.008148477,0.00018156793,0.00031560642,0.00008091124,0.015128671,0.00271971,0.021014458,0.02730126,0.9245909],"study_design_scores_gemma":[0.000049734943,0.00022917359,0.00092537253,0.0035969992,0.00024374168,0.002205012,0.00008570552,0.016526934,0.003009616,0.030836564,0.9421731,0.000118056],"about_ca_topic_score_codex":0.0018608095,"about_ca_topic_score_gemma":0.0014093153,"teacher_disagreement_score":0.0028675813,"about_ca_system_score_codex":0.0009895661,"about_ca_system_score_gemma":0.0013245259,"threshold_uncertainty_score":0.012113929},"labels":[],"label_agreement":null},{"id":"W2137655692","doi":"10.1517/17425255.2013.834886","title":"Keratoconus and crosslinking: pharmacokinetic considerations","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto","funders":"","keywords":"Keratoconus; Cornea; Medicine; Ophthalmology; Astigmatism; Pharmacokinetics; Pathogenesis; Bioinformatics; Pathology; Internal medicine; Biology","score_opus":0.08731303722993049,"score_gpt":0.39869909578684176,"score_spread":0.31138605855691126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137655692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012265827,0.99828774,0.00011254435,0.0004330278,0.00017426224,0.0000047411195,0.000012684445,0.000004757946,0.00084753387],"genre_scores_gemma":[0.0013565,0.996994,0.0001974543,0.0003676501,0.00027096138,0.0000073604942,0.000025084304,0.0000016147425,0.0007793863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971586,0.000052712872,0.000043941975,0.000044064804,0.00011942822,0.000023898381],"domain_scores_gemma":[0.99958736,0.00019646029,0.000082017905,0.000011373063,0.00010308072,0.00001975721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068087544,0.0006746976,0.0012847045,0.0016413375,0.0002755958,0.00087366236,0.00067569566,0.0013184174,0.0038751736],"category_scores_gemma":[0.00075254776,0.00027762438,0.00063285726,0.0013122382,0.00048838335,0.0010971559,0.00043675033,0.0016996849,0.0019064095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096619,0.00008827859,0.00021386916,0.029299656,0.00010762111,0.00077576673,0.000093516224,0.00045700517,0.0031152905,0.004702596,0.037917882,0.92313194],"study_design_scores_gemma":[0.000022710077,0.00011090593,0.00073355116,0.004210115,0.000121581535,0.0049324394,0.0000632304,0.00012895114,0.0011461951,0.0020313298,0.9864782,0.000020746875],"about_ca_topic_score_codex":0.0015514991,"about_ca_topic_score_gemma":0.0023675843,"teacher_disagreement_score":0.0038751736,"about_ca_system_score_codex":0.00052126776,"about_ca_system_score_gemma":0.0008139737,"threshold_uncertainty_score":0.012963712},"labels":[],"label_agreement":null},{"id":"W2141108781","doi":"10.1517/17425255.4.10.1245","title":"A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Nova Scotia Health Research Foundation","keywords":"P-glycoprotein; Inflammation; Blood–brain barrier; In vivo; Immunology; Transporter; Glycoprotein; Medicine; In vitro; Downregulation and upregulation; Neuroinflammation; Biology; Central nervous system; Pharmacology; Internal medicine; Drug resistance; Biochemistry","score_opus":0.04490207648889131,"score_gpt":0.3665675892566628,"score_spread":0.32166551276777144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141108781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016962602,0.9973266,0.00024074117,0.00058054045,0.0006116022,0.0000114867835,0.0000362159,0.000009566662,0.0010136236],"genre_scores_gemma":[0.00049911236,0.99783,0.00033076358,0.00030717035,0.00039335634,0.00001574389,0.00004917487,0.0000015587967,0.0005732416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997223,0.00005133384,0.00005887037,0.000043099324,0.00009876444,0.000025622347],"domain_scores_gemma":[0.9995832,0.00015626171,0.00005301606,0.000010317455,0.00017011166,0.000027068816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006664717,0.00131816,0.0018018048,0.002698915,0.00027010677,0.000937165,0.00086301053,0.001239829,0.0030567993],"category_scores_gemma":[0.00073780114,0.00036384564,0.0006862705,0.0025260109,0.00038315755,0.0017924998,0.0004064824,0.0014710543,0.0019427569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015896387,0.000086258195,0.00022468054,0.035162177,0.00015793408,0.0008363904,0.00009920723,0.00042720963,0.0051621627,0.002758265,0.08450914,0.8704176],"study_design_scores_gemma":[0.000025301262,0.00017808106,0.0016148733,0.006291976,0.00020584548,0.0027076013,0.00008642775,0.00015218765,0.0012556859,0.0015479441,0.9859035,0.000030705673],"about_ca_topic_score_codex":0.0013933266,"about_ca_topic_score_gemma":0.0021394459,"teacher_disagreement_score":0.0030567993,"about_ca_system_score_codex":0.0010542806,"about_ca_system_score_gemma":0.0014433366,"threshold_uncertainty_score":0.010226011},"labels":[],"label_agreement":null},{"id":"W2143341301","doi":"10.1517/17425255.4.4.471","title":"Pantoprazole: from drug metabolism to clinical relevance","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pantoprazole; Drug metabolism; Drug; Clinical significance; Medicine; Pharmacology; Internal medicine; Omeprazole","score_opus":0.08086610940193317,"score_gpt":0.4258679459393207,"score_spread":0.34500183653738753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143341301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045813373,0.9949202,0.00014948299,0.0028215556,0.00041142007,0.000007160671,0.00004011262,0.000009262444,0.0011827092],"genre_scores_gemma":[0.012575471,0.9819156,0.0002955977,0.002329467,0.0016299123,0.000021586899,0.00008551441,0.000009823382,0.0011370378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989563,0.0003072738,0.00016203884,0.00015292522,0.00035635917,0.00006506521],"domain_scores_gemma":[0.9980932,0.0009980012,0.00034746982,0.000031286156,0.00047195406,0.000058053807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011032383,0.000679761,0.0014846185,0.0018763739,0.00022461287,0.0017241011,0.0007689848,0.0012986511,0.00619113],"category_scores_gemma":[0.003276894,0.00027267172,0.00056877045,0.003010335,0.0009821338,0.0018404305,0.0008849836,0.0015581731,0.001993052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037414345,0.000060636732,0.0014113748,0.061432645,0.0002265863,0.0014129941,0.00029848385,0.00049110915,0.0019233292,0.006019063,0.065908015,0.8604415],"study_design_scores_gemma":[0.00014682628,0.0005067389,0.007880709,0.038983963,0.00060318905,0.00865477,0.00053395785,0.00042521305,0.0014711819,0.014028139,0.92669517,0.00007014058],"about_ca_topic_score_codex":0.001919877,"about_ca_topic_score_gemma":0.0018824171,"teacher_disagreement_score":0.00619113,"about_ca_system_score_codex":0.0013327613,"about_ca_system_score_gemma":0.0024257714,"threshold_uncertainty_score":0.020711422},"labels":[],"label_agreement":null},{"id":"W2151879652","doi":"10.1517/17425255.2014.931371","title":"Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Hemodialysis; Pharmacokinetics; Kidney disease; Dialysis; Polypharmacy; Intensive care medicine; Renal function; Adverse effect; Pharmacology; Internal medicine; Drug","score_opus":0.036785702129898054,"score_gpt":0.3620691050414009,"score_spread":0.3252834029115028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151879652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000146894,0.9973863,0.00016428567,0.0008736616,0.00031808787,0.0000061765054,0.00002105947,0.000005559355,0.0010779261],"genre_scores_gemma":[0.0016547133,0.99617517,0.00028439832,0.00068323093,0.000519576,0.000010349708,0.000041427465,0.0000016619985,0.0006294573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995468,0.000119529825,0.00008265216,0.00005421329,0.00017117172,0.000025453908],"domain_scores_gemma":[0.9993055,0.00034620095,0.00013751577,0.000012225816,0.00016601749,0.000032596177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065572787,0.00058517256,0.0012644533,0.0013265932,0.00022212432,0.0008723667,0.00065537205,0.0012764977,0.0032563505],"category_scores_gemma":[0.0016050776,0.0001673389,0.00079129473,0.0012112557,0.00034262467,0.0009437766,0.00050149375,0.001578256,0.0013425376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009289877,0.00006261876,0.0005587743,0.02944719,0.00014889475,0.0005233131,0.0001228899,0.00037285668,0.0009244257,0.0035593417,0.061195802,0.9029909],"study_design_scores_gemma":[0.000024589735,0.00010178582,0.001792056,0.010260274,0.00018570574,0.004244099,0.00010390161,0.00018415973,0.00039512877,0.0026445244,0.9800381,0.000025660811],"about_ca_topic_score_codex":0.0011906656,"about_ca_topic_score_gemma":0.0019570542,"teacher_disagreement_score":0.0032563505,"about_ca_system_score_codex":0.00048702685,"about_ca_system_score_gemma":0.0009895472,"threshold_uncertainty_score":0.010893583},"labels":[],"label_agreement":null},{"id":"W2152357527","doi":"10.1517/17425255.2015.1000859","title":"Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ambrisentan; Bosentan; Endothelin receptor antagonist; Medicine; Pulmonary hypertension; Pharmacology; Pharmacodynamics; Endothelin receptor; Internal medicine; Heart failure; Pharmacokinetics; Cardiology; Receptor","score_opus":0.15849946348034993,"score_gpt":0.4352394019230084,"score_spread":0.2767399384426585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152357527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013465558,0.99602926,0.00035752542,0.0004899628,0.00020195372,0.000016893484,0.000050784933,0.000006422992,0.0015006023],"genre_scores_gemma":[0.014023358,0.98273844,0.0006830487,0.0006004366,0.00028904233,0.00002991839,0.000118265,0.0000039234174,0.0015135559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979013,0.000059839607,0.000026785034,0.000028050592,0.00007952752,0.000015626196],"domain_scores_gemma":[0.99973947,0.00009431676,0.00006944965,0.0000051812967,0.00007533018,0.000016250979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064310705,0.00040311017,0.000954032,0.0005674966,0.00009938057,0.00058994966,0.0005223687,0.0006847467,0.0027724537],"category_scores_gemma":[0.0008008383,0.00011666187,0.00064511417,0.00053823006,0.00014010114,0.0004496203,0.00020877676,0.00091977883,0.0009155601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060317747,0.00016907633,0.00041449175,0.023760812,0.00040412086,0.00040208915,0.000062517036,0.00074018765,0.010441087,0.0018912876,0.016305989,0.9448052],"study_design_scores_gemma":[0.00057762617,0.0024146338,0.006034581,0.009477468,0.0017465311,0.006359037,0.00011346106,0.0014120234,0.008714761,0.0020158596,0.9610473,0.000086709835],"about_ca_topic_score_codex":0.00045768902,"about_ca_topic_score_gemma":0.0009805976,"teacher_disagreement_score":0.0027724537,"about_ca_system_score_codex":0.00028514632,"about_ca_system_score_gemma":0.0006127815,"threshold_uncertainty_score":0.009274781},"labels":[],"label_agreement":null},{"id":"W2153973088","doi":"10.1517/17425255.4.3.281","title":"The hepatic safety profile of duloxetine: a review","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Duloxetine; Duloxetine Hydrochloride; Medicine; Alanine aminotransferase; Safety profile; Placebo; Internal medicine; Liver enzyme; Pharmacology; Adverse effect; Gastroenterology; Pathology; Alternative medicine","score_opus":0.041025657868338714,"score_gpt":0.375229954708718,"score_spread":0.3342042968403793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153973088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019612804,0.9994875,0.000019964424,0.00006544229,0.000026537502,0.000006357464,0.000020389956,0.0000022223899,0.00017540077],"genre_scores_gemma":[0.0014703231,0.9982596,0.00007092721,0.00006732008,0.00003562504,0.0000070990236,0.000020923377,4.6899245e-7,0.000067638495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961424,0.000074571915,0.0001069901,0.000049748756,0.0001327499,0.000021624932],"domain_scores_gemma":[0.9986821,0.0006929087,0.00037731003,0.000016558773,0.00019634263,0.000034813555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008336326,0.00072229345,0.002273322,0.0037867131,0.00023354679,0.0008223499,0.0008888532,0.000857423,0.0028011054],"category_scores_gemma":[0.0019512195,0.00035107107,0.0009973461,0.0045432877,0.00028787818,0.00077715784,0.0003258708,0.00041664796,0.0005316875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026769465,0.000047414993,0.0008041304,0.27228287,0.0008748929,0.00061397377,0.000097222844,0.00018713831,0.00097636186,0.0003922885,0.013503045,0.70995307],"study_design_scores_gemma":[0.0003637418,0.0011786039,0.018183013,0.29911837,0.01642896,0.012017804,0.0004813714,0.00047310168,0.0024167278,0.0012592749,0.64798474,0.00009415863],"about_ca_topic_score_codex":0.0026620126,"about_ca_topic_score_gemma":0.005184226,"teacher_disagreement_score":0.0037867131,"about_ca_system_score_codex":0.00071312697,"about_ca_system_score_gemma":0.0017014634,"threshold_uncertainty_score":0.009370565},"labels":[],"label_agreement":null},{"id":"W2157776316","doi":"10.1517/17425250903273160","title":"Saquinavir, the pioneer antiretroviral protease inhibitor","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Saquinavir; Tolerability; Protease inhibitor (pharmacology); Medicine; Pill; Pharmacology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Protease; ANTIRETROVIRAL AGENTS; Intensive care medicine; Virology; Viral load; Adverse effect; Biology","score_opus":0.041917384538215266,"score_gpt":0.3556561561045075,"score_spread":0.31373877156629226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157776316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016183409,0.99778444,0.00015272773,0.00026735853,0.00016850999,0.000005491169,0.000011176502,0.000008375636,0.0014401409],"genre_scores_gemma":[0.0019664876,0.9960312,0.00040731978,0.0002489191,0.00035326715,0.0000060828665,0.000029740799,0.0000015131751,0.0009555284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996997,0.000052183583,0.00003487715,0.00005959263,0.00013247768,0.000021099018],"domain_scores_gemma":[0.99963546,0.00013890133,0.000076047654,0.000009172298,0.000110711284,0.000029672481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052864436,0.00071123266,0.0008834006,0.0017317614,0.00021971778,0.00067653786,0.00066286925,0.00087227655,0.003366691],"category_scores_gemma":[0.00055123545,0.0002053712,0.00038168815,0.0015235947,0.0003222014,0.0007649095,0.0003347321,0.0010049734,0.0033246297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054118802,0.000048413014,0.00028176478,0.010506669,0.000052722404,0.00038833581,0.000043897562,0.00018660832,0.0039944416,0.0013628757,0.01571814,0.967362],"study_design_scores_gemma":[0.000027813832,0.0001852595,0.0011781555,0.00204219,0.000096015254,0.0055960678,0.000047002253,0.0000905018,0.0015887842,0.0010116248,0.9881196,0.000017003018],"about_ca_topic_score_codex":0.0007458765,"about_ca_topic_score_gemma":0.0010737946,"teacher_disagreement_score":0.003366691,"about_ca_system_score_codex":0.00036204228,"about_ca_system_score_gemma":0.0007765671,"threshold_uncertainty_score":0.011262655},"labels":[],"label_agreement":null},{"id":"W2162652559","doi":"10.1517/17425255.2012.680886","title":"An update on the ability of St. John's wort to affect the metabolism of other drugs","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacology; Hypericum perforatum; Hyperforin; Medicine; CYP2C19; CYP2D6; Pharmacokinetics; CYP3A4; Drug interaction; Drug; CYP2C9; Pharmacogenomics; Bioavailability; Cytochrome P450; Metabolism; Internal medicine","score_opus":0.07119723126986381,"score_gpt":0.36851793229681246,"score_spread":0.29732070102694863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162652559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016808062,0.9971022,0.00004954911,0.00082386774,0.0006331257,0.000010566712,0.000081201084,0.000005317986,0.0011260104],"genre_scores_gemma":[0.0013497305,0.9957598,0.00023310889,0.0013643097,0.00057458295,0.000022088932,0.00012680523,0.0000024577334,0.0005672025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904114,0.0002063466,0.00034282397,0.00008359121,0.00028569344,0.000040283183],"domain_scores_gemma":[0.99635136,0.0022476623,0.000562629,0.000052884683,0.0006992502,0.00008618721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014243495,0.0006904362,0.002247026,0.0036560248,0.00028434792,0.0012061989,0.0011877301,0.0018835838,0.0071680606],"category_scores_gemma":[0.0042257886,0.00032769018,0.0018521785,0.0035204412,0.00039179198,0.0016566758,0.0005845521,0.0015049523,0.0015686832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027618397,0.00007142986,0.00042337927,0.14972739,0.00065132877,0.00070718664,0.00018350456,0.00018475692,0.000880189,0.0014341961,0.107919306,0.73754114],"study_design_scores_gemma":[0.00009408098,0.00024861752,0.0030803485,0.058489095,0.0016961197,0.0034423615,0.00011854223,0.00008404211,0.00030151423,0.00063066074,0.931779,0.000035583464],"about_ca_topic_score_codex":0.002438713,"about_ca_topic_score_gemma":0.0056169545,"teacher_disagreement_score":0.0071680606,"about_ca_system_score_codex":0.0009556081,"about_ca_system_score_gemma":0.0016798147,"threshold_uncertainty_score":0.023979545},"labels":[],"label_agreement":null},{"id":"W2167141172","doi":"10.1517/17425255.2013.788150","title":"Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Boniface Hospital","funders":"","keywords":"Pharmacodynamics; Medicine; Pharmacokinetics; Pneumonia; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.08233116649180026,"score_gpt":0.421501021977115,"score_spread":0.3391698554853147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167141172","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73357344,0.2438327,0.006429076,0.0035104174,0.0004159653,0.0005270866,0.0015226034,0.0002736579,0.009915063],"genre_scores_gemma":[0.9710733,0.024029715,0.002321713,0.0006146793,0.00014720224,0.000104021696,0.0006308047,0.00002222839,0.0010563285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960715,0.0001923631,0.000032515683,0.000053422402,0.000084359854,0.000030194484],"domain_scores_gemma":[0.9992669,0.00032120978,0.00022910928,0.000020474652,0.000096205826,0.00006609766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043895937,0.00024127257,0.0007743067,0.00030799667,0.000070279064,0.0006186771,0.00026286588,0.00040206857,0.0019616922],"category_scores_gemma":[0.0019821613,0.00008145514,0.0004708217,0.00030482566,0.00014065705,0.00024238393,0.00012459276,0.00053829385,0.00034089814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05363621,0.0017196222,0.010800834,0.00886291,0.001313663,0.0011436777,0.00020206286,0.0033467112,0.15247624,0.0010219399,0.00849144,0.7569847],"study_design_scores_gemma":[0.03495701,0.22845587,0.16967602,0.004837844,0.007737745,0.016494764,0.0007182198,0.037989188,0.29825425,0.0018376887,0.19860251,0.00043896356],"about_ca_topic_score_codex":0.00046541376,"about_ca_topic_score_gemma":0.0008101032,"teacher_disagreement_score":0.0019616922,"about_ca_system_score_codex":0.0003932317,"about_ca_system_score_gemma":0.00045776492,"threshold_uncertainty_score":0.0065624714},"labels":[],"label_agreement":null},{"id":"W2167719907","doi":"10.1517/17425255.2013.799137","title":"Drug absorption, distribution, metabolism and excretion considerations in critically ill adults","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"ADME; Pharmacokinetics; Drug; Critically ill; Excretion; Medicine; Distribution (mathematics); Drug metabolism; Pharmacology; Metabolic clearance rate; Intensive care medicine; Internal medicine","score_opus":0.09864579190547527,"score_gpt":0.4382375260399172,"score_spread":0.33959173413444194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167719907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015619662,0.99837995,0.00016692853,0.0004185164,0.00012657513,0.0000054893553,0.00001743835,0.000005342956,0.00072361436],"genre_scores_gemma":[0.001711148,0.99688244,0.00029399304,0.00031499518,0.00022789523,0.000009136732,0.000030097854,0.0000014782786,0.000528879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963355,0.0000927399,0.00006939436,0.000049819748,0.00013278337,0.000021719829],"domain_scores_gemma":[0.9995358,0.00022620462,0.0001084486,0.000008043141,0.0001023599,0.000019185301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060756964,0.00056697294,0.0013180602,0.0011893524,0.00014874754,0.00077708677,0.00056502194,0.001046171,0.0027584801],"category_scores_gemma":[0.0010714817,0.0001813809,0.0006348463,0.0010495206,0.0003153452,0.0008992703,0.00036987072,0.0013136382,0.001314389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012794997,0.00004763064,0.00033478622,0.030075021,0.00014364676,0.00046575424,0.00007046761,0.00034567268,0.002092485,0.002344173,0.025486885,0.9384655],"study_design_scores_gemma":[0.000043668042,0.00026051083,0.0024433518,0.009726312,0.00037177477,0.0057513355,0.00011488003,0.00034912236,0.0014571466,0.002658142,0.9767892,0.000034520817],"about_ca_topic_score_codex":0.0011737869,"about_ca_topic_score_gemma":0.0016015649,"teacher_disagreement_score":0.0027584801,"about_ca_system_score_codex":0.0004178707,"about_ca_system_score_gemma":0.00096047774,"threshold_uncertainty_score":0.009227991},"labels":[],"label_agreement":null},{"id":"W2289344428","doi":"10.1517/17425255.2016.1145656","title":"Current perspective on pediatric pharmacogenomics","year":2016,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacogenomics; Perspective (graphical); Medicine; Current (fluid); Intensive care medicine; Pharmacology; Computer science; Artificial intelligence","score_opus":0.04572779244795052,"score_gpt":0.4351858967498849,"score_spread":0.3894581043019344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289344428","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041946503,0.055670436,0.00027514712,0.13240135,0.80935174,0.000016598606,0.00007412345,0.00005063585,0.0021179598],"genre_scores_gemma":[0.00032302795,0.023719806,0.0002375201,0.048091944,0.92433345,0.000019123563,0.000032863518,0.000019707779,0.003222556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99248487,0.0018119905,0.0014303335,0.0007987184,0.0030039018,0.00047031944],"domain_scores_gemma":[0.9546114,0.020136692,0.0044545075,0.0010918838,0.014741317,0.00496404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011811913,0.002809226,0.004320512,0.0043319915,0.0019489771,0.0073434943,0.0032434945,0.020244569,0.011580375],"category_scores_gemma":[0.040310245,0.001203717,0.0027784877,0.0022434455,0.0026837664,0.0052771275,0.0024871884,0.024530308,0.0075239185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020715997,0.000010495774,0.0000611579,0.0005043252,0.000040159044,0.00018042854,0.00001723124,0.000028431927,0.000031113555,0.0004914813,0.982698,0.015916465],"study_design_scores_gemma":[0.000062549705,0.000018118533,0.00021492412,0.0014292687,0.00010669967,0.0004284375,0.000031250656,0.0000742144,0.00003776126,0.0011768859,0.99640274,0.000017218434],"about_ca_topic_score_codex":0.0020879812,"about_ca_topic_score_gemma":0.006014638,"teacher_disagreement_score":0.020244569,"about_ca_system_score_codex":0.0039924565,"about_ca_system_score_gemma":0.0052957796,"threshold_uncertainty_score":0.06246811},"labels":[],"label_agreement":null},{"id":"W2320276397","doi":"10.1517/17425255.2016.1171317","title":"Clinical decision support systems: great promises for better management of patients’ drug therapy","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Intensive care medicine; Medicine; Drug; Clinical decision support system; Pharmacotherapy; Decision support system; Pharmacology; Internal medicine; Computer science; Data mining","score_opus":0.11844235520695492,"score_gpt":0.44032431422659074,"score_spread":0.3218819590196358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320276397","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007881437,0.08109743,0.078030884,0.7911569,0.010822735,0.00024844275,0.002631766,0.0023205695,0.02580985],"genre_scores_gemma":[0.20292087,0.22861572,0.35163382,0.13793632,0.05863812,0.0007395577,0.0067510027,0.0006200262,0.012144538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9882549,0.0074182427,0.0009151929,0.0006686875,0.0023966006,0.00034639382],"domain_scores_gemma":[0.931551,0.041357864,0.005721723,0.0034470735,0.010574736,0.007347749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020452527,0.0013776736,0.0021612595,0.0016243476,0.00071904354,0.009104186,0.0026107535,0.004630615,0.016399233],"category_scores_gemma":[0.05473096,0.00048207943,0.0016344175,0.001557209,0.001470415,0.008609603,0.0032137427,0.007652248,0.008002559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004524754,0.0004279563,0.005564664,0.0022777237,0.0007105428,0.00016250742,0.00033592505,0.00514559,0.0010514435,0.03376252,0.27888516,0.6712235],"study_design_scores_gemma":[0.0007409078,0.00062517734,0.006101665,0.006009099,0.00037801178,0.00057754805,0.0009721955,0.027644044,0.0011365912,0.283202,0.6722855,0.0003271644],"about_ca_topic_score_codex":0.0012714537,"about_ca_topic_score_gemma":0.0021002397,"teacher_disagreement_score":0.020452527,"about_ca_system_score_codex":0.0020453355,"about_ca_system_score_gemma":0.004653314,"threshold_uncertainty_score":0.10816461},"labels":[],"label_agreement":null},{"id":"W2411996261","doi":"10.1080/17425255.2016.1194394","title":"Pharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Pharmacogenomics; Medicine; Psoriatic arthritis; Psoriasis; Pharmacogenetics; Disease; Intensive care medicine; Personalized medicine; Clinical trial; Adverse effect; Precision medicine; Bioinformatics; Pharmacology; Internal medicine; Dermatology; Pathology","score_opus":0.05894967176582562,"score_gpt":0.34760396465932103,"score_spread":0.2886542928934954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411996261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007561042,0.99734795,0.00024626352,0.0018253949,0.00016316486,0.0000029668583,0.000008624047,0.0000061090054,0.00032388917],"genre_scores_gemma":[0.0007732963,0.99783057,0.00033608565,0.0005063751,0.0003715346,0.0000052394125,0.0000128515485,0.0000015534714,0.00016244354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932563,0.00024591785,0.00008470963,0.000103156475,0.00019173302,0.000048900096],"domain_scores_gemma":[0.9974522,0.0016413734,0.00025256808,0.00005530888,0.00047448307,0.00012407477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002853929,0.0007290741,0.002117866,0.0014128172,0.00023725202,0.0016790911,0.0010631856,0.001908513,0.0027817502],"category_scores_gemma":[0.0027781308,0.00026789526,0.0008965625,0.002029903,0.0009414671,0.0016890053,0.00090009416,0.002760993,0.0011653351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007290777,0.000067344095,0.00050346245,0.011348932,0.0001773597,0.00016386689,0.0000701968,0.0005606498,0.0005507239,0.0065027736,0.023287175,0.9566946],"study_design_scores_gemma":[0.000042945176,0.00015909664,0.0026920834,0.013208463,0.00038554354,0.0016808955,0.00020410768,0.00060051837,0.00043423582,0.017738678,0.9628007,0.000052819036],"about_ca_topic_score_codex":0.0014654603,"about_ca_topic_score_gemma":0.0026030343,"teacher_disagreement_score":0.002853929,"about_ca_system_score_codex":0.0009960751,"about_ca_system_score_gemma":0.002287974,"threshold_uncertainty_score":0.015093207},"labels":[],"label_agreement":null},{"id":"W2480704692","doi":"10.1080/17425255.2016.1215426","title":"Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sugammadex; Rocuronium; Medicine; Neuromuscular Blockade; Muscle relaxant; Anesthesia; Neuromuscular Blocking Agents; Neuromuscular transmission; Rocuronium Bromide; Myasthenia gravis; Pharmacology; Intensive care medicine; Propofol; Internal medicine","score_opus":0.07850930446450471,"score_gpt":0.434656036027753,"score_spread":0.3561467315632483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480704692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021534464,0.99876,0.00008005798,0.00017672006,0.00007467634,0.000005142604,0.000016440881,0.000002911377,0.0006687752],"genre_scores_gemma":[0.0020608741,0.9972356,0.00014750853,0.000114586626,0.00011569689,0.0000082761,0.00002682871,9.783342e-7,0.00028966804],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99961036,0.00007796138,0.00009530808,0.000057571695,0.00013666843,0.00002213277],"domain_scores_gemma":[0.99943966,0.00026440452,0.00012493387,0.00001122185,0.00013913275,0.000020584983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065470004,0.00060606614,0.0012220383,0.0013547466,0.00014925076,0.00079988845,0.00058413413,0.00092068984,0.0031440759],"category_scores_gemma":[0.0013249998,0.00016831474,0.0007671677,0.0010869075,0.0003187426,0.0006877168,0.00040625053,0.0009772303,0.0012493981],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001931449,0.00007812963,0.00036331455,0.04165121,0.0002622155,0.00030602643,0.00007132064,0.0003077256,0.0021473083,0.0016268999,0.010498182,0.94249445],"study_design_scores_gemma":[0.00015957153,0.0006968914,0.006229484,0.032256138,0.0012464636,0.007812406,0.00016048967,0.00043634145,0.003102257,0.0029058668,0.94493175,0.0000623664],"about_ca_topic_score_codex":0.00064321095,"about_ca_topic_score_gemma":0.0011091607,"teacher_disagreement_score":0.0031440759,"about_ca_system_score_codex":0.0003632253,"about_ca_system_score_gemma":0.00078128604,"threshold_uncertainty_score":0.010518014},"labels":[],"label_agreement":null},{"id":"W2509894219","doi":"10.1080/17425255.2016.1214711","title":"The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo","funders":"","keywords":"Pharmacokinetics; Dosing; Medicine; Population; Clotting factor; Factor IX; Von Willebrand factor; Pharmacology; Intensive care medicine; Internal medicine; Platelet","score_opus":0.10240398716284912,"score_gpt":0.385059631105346,"score_spread":0.28265564394249687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509894219","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031504445,0.6420796,0.28787914,0.020441374,0.0014278895,0.00042909337,0.0011859947,0.00053546316,0.014517019],"genre_scores_gemma":[0.4610025,0.39520368,0.12771381,0.006967132,0.002709526,0.0005385834,0.00083220046,0.00036829914,0.0046643433],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99553585,0.0027373852,0.00021909775,0.00053016905,0.0009231858,0.000054380274],"domain_scores_gemma":[0.9905183,0.0064118095,0.0017054733,0.00032712528,0.0009453793,0.000092063274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070376564,0.000494508,0.0011632511,0.00059857464,0.00015600065,0.0015253273,0.000812789,0.0010546618,0.0023132148],"category_scores_gemma":[0.01908206,0.00024136322,0.0011569198,0.00081447914,0.0005384476,0.0011440896,0.0004681752,0.0019668168,0.00077273004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008862003,0.00014077235,0.01014782,0.0038767334,0.0009253447,0.00022287965,0.00019337362,0.017695932,0.008611707,0.012892251,0.017978232,0.9264288],"study_design_scores_gemma":[0.0006468167,0.0061186426,0.07014094,0.006583115,0.003714657,0.008694843,0.00034122344,0.12276226,0.03830637,0.070676684,0.67157227,0.00044226076],"about_ca_topic_score_codex":0.0014990824,"about_ca_topic_score_gemma":0.0013116616,"teacher_disagreement_score":0.0070376564,"about_ca_system_score_codex":0.0013598346,"about_ca_system_score_gemma":0.0013037807,"threshold_uncertainty_score":0.037219107},"labels":[],"label_agreement":null},{"id":"W2611085069","doi":"10.1080/17425255.2017.1325873","title":"Pharmacokinetic and pharmacodynamic alterations in older people with dementia","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Dementia; Medicine; Pharmacodynamics; Pharmacokinetics; Quality of life (healthcare); Gerontology; Intensive care medicine; Pharmacology; Disease; Internal medicine","score_opus":0.13546893756654144,"score_gpt":0.472841714808296,"score_spread":0.3373727772417546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611085069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027389204,0.9978713,0.00011132151,0.0007186529,0.00015988968,0.000007706924,0.00004176488,0.000005655066,0.00080973725],"genre_scores_gemma":[0.0039873556,0.994555,0.00022762024,0.0005112837,0.00021932049,0.000012039365,0.0000437965,0.0000014754983,0.0004420317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993462,0.00017876162,0.00011626485,0.00008417279,0.00024000973,0.000034576944],"domain_scores_gemma":[0.9988456,0.000571262,0.00030040598,0.000017451974,0.00023669752,0.000028576327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009093531,0.0005310825,0.0013503213,0.0012915025,0.0001617201,0.000877146,0.0005987778,0.001108886,0.004022289],"category_scores_gemma":[0.002744432,0.00015598504,0.0011489328,0.0009846915,0.00034618395,0.00073629274,0.00044181145,0.001104303,0.0007973771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016970941,0.000060905506,0.0010812122,0.082421385,0.00055922265,0.00044145097,0.00013981914,0.00039478723,0.0011848311,0.0022173293,0.030734569,0.88059473],"study_design_scores_gemma":[0.000094419316,0.000416127,0.007175594,0.0550701,0.0019646122,0.0063831005,0.00026104713,0.00044467527,0.0014637777,0.0047623506,0.9218981,0.00006614238],"about_ca_topic_score_codex":0.0016888686,"about_ca_topic_score_gemma":0.002856151,"teacher_disagreement_score":0.004022289,"about_ca_system_score_codex":0.00047523328,"about_ca_system_score_gemma":0.0011758277,"threshold_uncertainty_score":0.013455927},"labels":[],"label_agreement":null},{"id":"W2796082164","doi":"10.1080/17425255.2018.1459564","title":"Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder","year":2018,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Buprenorphine; Medicine; Tolerability; Clinical trial; Major depressive disorder; Pharmacodynamics; Opioidergic; Opioid use disorder; Pharmacology; Opioid; Adverse effect; Psychiatry; Internal medicine; Pharmacokinetics; Mood","score_opus":0.06073257827612015,"score_gpt":0.41633021195170944,"score_spread":0.3555976336755893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796082164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018458451,0.9991159,0.000045050037,0.00015042364,0.00005232603,0.000012266517,0.00002683038,0.0000019323159,0.00041077365],"genre_scores_gemma":[0.0026221767,0.99673045,0.00014753127,0.0001885033,0.00006904294,0.000015872076,0.000029307977,9.69624e-7,0.00019605485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995085,0.00012853442,0.00010948522,0.00006197819,0.00017108551,0.000020383484],"domain_scores_gemma":[0.999175,0.00046137927,0.00020476372,0.00001196341,0.00012754109,0.00001931676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011256498,0.0005340967,0.0016183679,0.001593127,0.00015168318,0.000730036,0.0007941134,0.00089009904,0.004146417],"category_scores_gemma":[0.0019911372,0.00019886793,0.001249513,0.0013320557,0.0002351347,0.00058402587,0.00032696215,0.0007267957,0.00068285293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021576622,0.00006467605,0.00029365762,0.1759837,0.00092126115,0.0002192301,0.00007901328,0.00026292386,0.0014326688,0.001059647,0.010580014,0.8088874],"study_design_scores_gemma":[0.00050530565,0.0011924828,0.006673067,0.16058038,0.0077566854,0.0056499876,0.00029625182,0.00057276385,0.0026363889,0.0020530357,0.8119903,0.00009325721],"about_ca_topic_score_codex":0.0009076388,"about_ca_topic_score_gemma":0.0021835028,"teacher_disagreement_score":0.004146417,"about_ca_system_score_codex":0.0004019904,"about_ca_system_score_gemma":0.0011382038,"threshold_uncertainty_score":0.013871193},"labels":[],"label_agreement":null},{"id":"W2797468464","doi":"10.1080/17425255.2018.1461834","title":"Common drug-drug interactions in antifungal treatments for superficial fungal infections","year":2018,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacodynamics; Drug; Antifungal drug; Pharmacokinetics; Pharmacology; Antifungal drugs; Antifungal; Context (archaeology); Medicine; Drug interaction; Fluconazole; Itraconazole; Ketoconazole; Biology; Dermatology","score_opus":0.07607299476750871,"score_gpt":0.4238169281777413,"score_spread":0.3477439334102326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797468464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028264543,0.99623424,0.00028844475,0.00082957774,0.00023366345,0.000015009274,0.000061287414,0.000012684938,0.0020425406],"genre_scores_gemma":[0.0029056903,0.9946142,0.00048347647,0.00060105923,0.00025830104,0.000015687823,0.000095903924,0.000003355004,0.0010222828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999338,0.0001555262,0.0001066038,0.00007861941,0.00028086978,0.000040302686],"domain_scores_gemma":[0.9991184,0.0004339928,0.00020046295,0.0000176645,0.0001978205,0.000031707776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063958234,0.000590011,0.0009717631,0.0015717661,0.00021760314,0.0008871153,0.00063383725,0.0011098689,0.005499694],"category_scores_gemma":[0.0015389844,0.00013814602,0.00086285075,0.0013291903,0.00033395528,0.0009017199,0.00044495473,0.0012618857,0.0014927783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071066024,0.000056445577,0.0003583842,0.032641314,0.00019905942,0.0004223464,0.0000926766,0.0003207386,0.0015992289,0.0025838024,0.03442807,0.92722684],"study_design_scores_gemma":[0.00002789293,0.00012334586,0.0016091452,0.013517437,0.00036745338,0.00425842,0.00009571125,0.00019620272,0.00092456257,0.0020447017,0.97681135,0.000023797755],"about_ca_topic_score_codex":0.00092966564,"about_ca_topic_score_gemma":0.002348613,"teacher_disagreement_score":0.005499694,"about_ca_system_score_codex":0.00049926253,"about_ca_system_score_gemma":0.0011890789,"threshold_uncertainty_score":0.018398285},"labels":[],"label_agreement":null},{"id":"W2954033311","doi":"10.1080/17425255.2019.1640679","title":"The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"In vivo; Albumin; Hepatocyte; In vitro; Allosteric regulation; Pharmacology; Drug; Plasma protein binding; Biology; Pharmacokinetics; Computational biology; Chemistry; Biochemistry; Receptor; Genetics","score_opus":0.02674877118527289,"score_gpt":0.319900522291127,"score_spread":0.29315175110585406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954033311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005519837,0.9164786,0.03281666,0.03531812,0.0031611028,0.000040751485,0.00022817249,0.00010701259,0.006329822],"genre_scores_gemma":[0.09846016,0.8565368,0.009938146,0.0205208,0.0067771263,0.00011850195,0.00034269897,0.000099913676,0.007205804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905413,0.0003608755,0.00006914307,0.00018872466,0.00023956438,0.00008745389],"domain_scores_gemma":[0.99806875,0.0013130856,0.00018944692,0.00005161159,0.0003267165,0.000050420047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002682488,0.00064108544,0.000950203,0.000850924,0.00036956463,0.0015038671,0.0012519849,0.0023744782,0.0034570962],"category_scores_gemma":[0.0022535322,0.00023851328,0.0011800067,0.000637821,0.0016161589,0.002340127,0.0009705778,0.0030303998,0.0013201092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000579634,0.000089389956,0.0023888536,0.02205298,0.00052908284,0.0021618202,0.0008582589,0.015642766,0.049448434,0.19398452,0.09347595,0.61878836],"study_design_scores_gemma":[0.000029362229,0.0004819388,0.0033834868,0.0040675285,0.00036048263,0.0028610723,0.00058630947,0.013463684,0.024961881,0.1283265,0.8213093,0.0001684253],"about_ca_topic_score_codex":0.0015958537,"about_ca_topic_score_gemma":0.001266015,"teacher_disagreement_score":0.0034570962,"about_ca_system_score_codex":0.0014856587,"about_ca_system_score_gemma":0.0009067307,"threshold_uncertainty_score":0.014186561},"labels":[],"label_agreement":null},{"id":"W3033555260","doi":"10.1080/17425255.2020.1780209","title":"An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Phenytoin; CYP2C9; Pharmacogenomics; Toxic epidermal necrolysis; Pharmacogenetics; Epilepsy; Medicine; Allele; Population; Pharmacology; Adverse effect; CYP2C19; Genotype; Biology; Genetics; Dermatology; Gene","score_opus":0.04949260187901375,"score_gpt":0.3865023177291637,"score_spread":0.33700971585014994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033555260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031826633,0.9808023,0.0006938608,0.010438697,0.004110801,0.000018286933,0.00017456464,0.00004955327,0.0033937371],"genre_scores_gemma":[0.0024901666,0.977047,0.0008691224,0.0067102956,0.009287909,0.000026549225,0.00038811588,0.0000122004485,0.0031686341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994289,0.0001581678,0.00010407926,0.0000694396,0.00020426353,0.000035124795],"domain_scores_gemma":[0.9981172,0.00096497696,0.00022836668,0.000036746205,0.0005557602,0.0000969562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092928094,0.00080091966,0.0014526858,0.0014318533,0.0002162715,0.0010256725,0.000868991,0.0018266541,0.008222897],"category_scores_gemma":[0.0025240388,0.00022327431,0.0011951278,0.0010871467,0.00030137767,0.0011627044,0.0005612794,0.0025892376,0.0028238145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010695433,0.000049322,0.00049077434,0.008908511,0.00023702778,0.00071536476,0.00004819361,0.00033576915,0.0008495624,0.001373497,0.24873286,0.7381522],"study_design_scores_gemma":[0.000044607452,0.00010062083,0.0013721776,0.0053878366,0.00038605265,0.0025092005,0.000036430567,0.0002160082,0.00021804127,0.0018500916,0.98785967,0.000019286119],"about_ca_topic_score_codex":0.0011187345,"about_ca_topic_score_gemma":0.0023533157,"teacher_disagreement_score":0.008222897,"about_ca_system_score_codex":0.0006410598,"about_ca_system_score_gemma":0.0008239069,"threshold_uncertainty_score":0.027508378},"labels":[],"label_agreement":null},{"id":"W3136809887","doi":"10.1080/17425255.2021.1899159","title":"Renal and non-renal response of ABC and SLC transporters in chronic kidney disease","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Kidney; Solute carrier family; Kidney disease; Renal function; ATP-binding cassette transporter; Homeostasis; Transporter; Context (archaeology); Biology; Organic anion transporter 1; Pharmacology; Bioinformatics; Medicine; Internal medicine; Endocrinology; Biochemistry","score_opus":0.02659565681889743,"score_gpt":0.3332205735561252,"score_spread":0.3066249167372278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136809887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015837283,0.99506396,0.00022862523,0.0018730649,0.00086592627,0.0000065642207,0.000045911584,0.000013403301,0.0017442724],"genre_scores_gemma":[0.0017202174,0.9943364,0.00023767777,0.0011064608,0.0008673321,0.00001225445,0.00008157064,0.0000027825083,0.0016353359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979085,0.000052066647,0.000019401243,0.000032126714,0.000083668376,0.00002193657],"domain_scores_gemma":[0.9997044,0.000105294974,0.000041127278,0.0000065605573,0.000118588694,0.000024046227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048228048,0.00050437654,0.0008282614,0.0008797542,0.00016196394,0.00082756125,0.0005461921,0.001165264,0.005979528],"category_scores_gemma":[0.0007747942,0.00011209528,0.00055147486,0.0008312767,0.00030212538,0.0008144796,0.00046202098,0.0016653341,0.0025268882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010368345,0.000036226702,0.00023261886,0.0133657595,0.00011876342,0.00017739949,0.000059778395,0.00033385746,0.0015442758,0.0067686266,0.09646594,0.88079315],"study_design_scores_gemma":[0.00002031371,0.000077112774,0.00073103874,0.003159642,0.00009786588,0.0007399322,0.000044121367,0.00014717183,0.00029822695,0.0029778078,0.9916939,0.000012849408],"about_ca_topic_score_codex":0.0007281427,"about_ca_topic_score_gemma":0.0015783281,"teacher_disagreement_score":0.005979528,"about_ca_system_score_codex":0.00050459703,"about_ca_system_score_gemma":0.0008742744,"threshold_uncertainty_score":0.020003557},"labels":[],"label_agreement":null},{"id":"W3207074037","doi":"10.1080/17425255.2021.1992382","title":"Antisense oligonucleotides: absorption, distribution, metabolism, and excretion","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; University of Ottawa","funders":"Sarepta Therapeutics","keywords":"ADME; Pharmacokinetics; Pharmacology; Morpholino; Chemistry; Oligonucleotide; Biochemistry; Medicine; Gene knockdown; DNA","score_opus":0.021186736686770912,"score_gpt":0.31708687808503216,"score_spread":0.29590014139826126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207074037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.117524885,0.7818973,0.064721964,0.007903644,0.0021524886,0.00027645103,0.0015785729,0.00090946053,0.02303519],"genre_scores_gemma":[0.65513694,0.304566,0.01744219,0.003349996,0.0016386749,0.00026644967,0.000981038,0.0001526866,0.01646603],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944097,0.00012478209,0.000042294694,0.00013583776,0.0002144537,0.00004158667],"domain_scores_gemma":[0.9994086,0.00020483055,0.0002055536,0.000017676173,0.00013951349,0.000023913399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007079286,0.000498682,0.0005288447,0.00025159545,0.00009159089,0.000773239,0.00019735562,0.00068757357,0.0023816186],"category_scores_gemma":[0.0010220011,0.00014698188,0.00043591284,0.0001691896,0.00034601882,0.0005410317,0.00018380367,0.00082309986,0.0008036141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008340298,0.00008341638,0.003766146,0.0072941347,0.0002054127,0.00095891015,0.00021463314,0.0027796885,0.50194937,0.0059560644,0.014971624,0.46098658],"study_design_scores_gemma":[0.00012861323,0.0044462024,0.015364185,0.001227945,0.00061338197,0.0151033765,0.00023525725,0.0069085318,0.50313926,0.0058884164,0.44680548,0.00013934338],"about_ca_topic_score_codex":0.0008082496,"about_ca_topic_score_gemma":0.0006329981,"teacher_disagreement_score":0.0023816186,"about_ca_system_score_codex":0.0005772557,"about_ca_system_score_gemma":0.00047659944,"threshold_uncertainty_score":0.007967293},"labels":[],"label_agreement":null},{"id":"W4362737450","doi":"10.1080/17425255.2023.2200161","title":"What is the significance of the impact of antipsychotics on the gut microbiome?","year":2023,"lang":"en","type":"letter","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Microbiome; Gut microbiome; Medicine; Clinical significance; Biology; Psychiatry; Bioinformatics; Internal medicine","score_opus":0.028425890914076733,"score_gpt":0.3318736150051657,"score_spread":0.303447724091089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362737450","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025536635,0.013013403,0.00017281786,0.9555677,0.030072037,0.0000064868373,0.00009499043,0.00003441139,0.00078280235],"genre_scores_gemma":[0.004469327,0.018478801,0.0003191444,0.81009334,0.16429925,0.000024296562,0.00007512428,0.00003181174,0.0022089013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736637,0.0007982944,0.00024001718,0.00035378337,0.00093388476,0.00030765546],"domain_scores_gemma":[0.9872457,0.007228452,0.0007264927,0.0003677463,0.0029999167,0.0014317625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034481548,0.00074476283,0.0025962342,0.00050555053,0.0016021194,0.0023725634,0.0021562807,0.027470315,0.0059442916],"category_scores_gemma":[0.021183586,0.00040631543,0.0012519092,0.0003271804,0.00251979,0.004907061,0.0012672655,0.02567691,0.006775525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014579856,0.000036513906,0.0005548044,0.00027035136,0.00004864109,0.0015244788,0.0000591208,0.000081493934,0.0005480861,0.0027319903,0.9518181,0.042180613],"study_design_scores_gemma":[0.00030953134,0.0002527806,0.0020255866,0.0010461786,0.00011178753,0.0040356023,0.00042195295,0.0007745331,0.00073402055,0.034175362,0.95597905,0.00013364028],"about_ca_topic_score_codex":0.004197986,"about_ca_topic_score_gemma":0.0058610057,"teacher_disagreement_score":0.027470315,"about_ca_system_score_codex":0.0029943346,"about_ca_system_score_gemma":0.002841118,"threshold_uncertainty_score":0.021725476},"labels":[],"label_agreement":null},{"id":"W4379207158","doi":"10.1080/17425255.2023.2221847","title":"Safety of medicines during breastfeeding – from case report to modeling: a contribution from the ConcePTION project","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Waterloo","funders":"Horizon 2020","keywords":"Breastfeeding; Physiologically based pharmacokinetic modelling; Medicine; Population; Family medicine; Pharmacokinetics; Environmental health; Pharmacology; Pediatrics","score_opus":0.09474706383444478,"score_gpt":0.4106605149052793,"score_spread":0.31591345107083446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379207158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036836062,0.97323996,0.004342075,0.010198065,0.0011708413,0.00013811329,0.00026373682,0.00004755022,0.0069160424],"genre_scores_gemma":[0.040285375,0.94772094,0.005460762,0.0024906034,0.0013575493,0.00016804288,0.00028550508,0.000039956485,0.0021913233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678874,0.0017081429,0.00040051003,0.00026628652,0.00073000335,0.000106364525],"domain_scores_gemma":[0.9921747,0.0055049937,0.00080722506,0.00037473388,0.0009660883,0.00017225146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005280405,0.00058462174,0.000846408,0.0015874775,0.00027203475,0.0012488135,0.00080417667,0.0015349801,0.0052443487],"category_scores_gemma":[0.018316917,0.00023854375,0.00105403,0.0011298029,0.00063451176,0.0010370545,0.0009600162,0.0014708542,0.0013453729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015958825,0.00008744131,0.0031989308,0.018901607,0.00025129894,0.00388995,0.0006837105,0.00059396494,0.000604941,0.006241778,0.03303992,0.9323468],"study_design_scores_gemma":[0.00007589877,0.00032225478,0.0063165375,0.05601775,0.0012321044,0.043629907,0.00083439186,0.0008774073,0.0021476257,0.008938619,0.8795048,0.00010277372],"about_ca_topic_score_codex":0.0024770421,"about_ca_topic_score_gemma":0.0022686385,"teacher_disagreement_score":0.005280405,"about_ca_system_score_codex":0.0008749611,"about_ca_system_score_gemma":0.0032158238,"threshold_uncertainty_score":0.02792579},"labels":[],"label_agreement":null},{"id":"W4381599207","doi":"10.1080/17425255.2023.2228680","title":"The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Drug; Drug metabolism; CYP3A4; Cytochrome P450; Coronavirus disease 2019 (COVID-19); Virology; Biology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pharmacology; Medicine; Metabolism; Infectious disease (medical specialty); Disease; Internal medicine; Biochemistry","score_opus":0.07521101245961502,"score_gpt":0.46952742211583703,"score_spread":0.394316409656222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381599207","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016189938,0.084976904,0.0004314279,0.09768957,0.81032854,0.000043941312,0.0002560012,0.00009981039,0.006011928],"genre_scores_gemma":[0.0014399384,0.068989575,0.00028452804,0.04717416,0.8682749,0.000028782168,0.00017745791,0.00006207694,0.013568631],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980724,0.00036877557,0.00019992107,0.0002521863,0.00097555044,0.00013127735],"domain_scores_gemma":[0.99238175,0.0030137643,0.0004555661,0.0001420823,0.0032904842,0.0007163911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034133857,0.0010835531,0.0018555208,0.0009822976,0.0009135907,0.0029956973,0.001981372,0.0081636,0.012941349],"category_scores_gemma":[0.011407864,0.00043294334,0.0013538819,0.00057590957,0.0010198113,0.0024882888,0.0008577625,0.009430604,0.009853861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046296795,0.0000070393,0.000027467111,0.0004952757,0.00002404344,0.000116685755,0.000012903322,0.000021502019,0.000116389674,0.00048088463,0.97826743,0.020383991],"study_design_scores_gemma":[0.00005415326,0.000044294306,0.00018341331,0.00062812,0.00006156668,0.00038387362,0.000022677817,0.00007872531,0.00013985163,0.0010804533,0.99730957,0.00001319643],"about_ca_topic_score_codex":0.001096343,"about_ca_topic_score_gemma":0.002813481,"teacher_disagreement_score":0.012941349,"about_ca_system_score_codex":0.0015341049,"about_ca_system_score_gemma":0.0016526356,"threshold_uncertainty_score":0.043293178},"labels":[],"label_agreement":null},{"id":"W4393902689","doi":"10.1080/17425255.2024.2339397","title":"Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Drug; Coronavirus disease 2019 (COVID-19); Medicine; Adverse effect; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Intensive care medicine; Virology; Pharmacology; Disease; Infectious disease (medical specialty); Outbreak; Internal medicine","score_opus":0.15530939311221637,"score_gpt":0.5037821129737068,"score_spread":0.3484727198614904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393902689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001058265,0.9980829,0.00005975315,0.0001762787,0.000049523638,0.00015581009,0.00028695218,0.0000037281416,0.00012677397],"genre_scores_gemma":[0.022889026,0.9752239,0.00043731366,0.00063497,0.00009681643,0.00037173607,0.00026055166,0.0000036100782,0.000081989034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920236,0.0024416528,0.0033880218,0.0005613226,0.0014006038,0.0001848521],"domain_scores_gemma":[0.96159583,0.02663216,0.0085222125,0.00047717837,0.0024728342,0.0002997243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007850558,0.0010755064,0.006405963,0.010136764,0.0004962355,0.0020680784,0.0012353978,0.0017179839,0.0027207045],"category_scores_gemma":[0.03150322,0.0007603267,0.007086319,0.009757404,0.0007611071,0.0020985263,0.0011382668,0.0010192663,0.00017251134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018732804,0.00001291021,0.0016922444,0.96425104,0.0077799754,0.00010631572,0.00012300372,0.0000626651,0.00009540646,0.00010434701,0.0009148963,0.024669813],"study_design_scores_gemma":[0.000254184,0.00031289295,0.010846585,0.9006972,0.070847236,0.0008806592,0.00032680063,0.00010789322,0.00018633425,0.0002748361,0.015219411,0.000045903227],"about_ca_topic_score_codex":0.005730681,"about_ca_topic_score_gemma":0.014966664,"teacher_disagreement_score":0.010136764,"about_ca_system_score_codex":0.0026187967,"about_ca_system_score_gemma":0.007425606,"threshold_uncertainty_score":0.04151821},"labels":[],"label_agreement":null},{"id":"W4396697650","doi":"10.1080/17425255.2024.2349711","title":"Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn’s disease","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Crohn's disease; Therapeutic drug monitoring; Disease; Pharmacology; Internal medicine","score_opus":0.04476658529614437,"score_gpt":0.38001605421378515,"score_spread":0.3352494689176408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396697650","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.446826,0.5007146,0.014435983,0.0078105032,0.0014230747,0.00082235975,0.0047226967,0.0004173636,0.022827419],"genre_scores_gemma":[0.88062125,0.0994809,0.0062373104,0.0030392383,0.00092869427,0.00033944054,0.0034022308,0.00014312661,0.0058078305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99948263,0.00020912633,0.000036324833,0.00007892717,0.0001496778,0.000043338816],"domain_scores_gemma":[0.9992422,0.00026651914,0.00022115599,0.000032327327,0.00015808457,0.000079714846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012144032,0.00026738338,0.0011888519,0.00026254653,0.00010840799,0.00104427,0.00025395487,0.00054505945,0.0039306586],"category_scores_gemma":[0.0021095714,0.00013928289,0.00068378675,0.00039609004,0.00014520077,0.00047321603,0.00018895701,0.0009812317,0.0009610183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03781746,0.0008559141,0.026419625,0.0072231716,0.0023528598,0.0010786162,0.00019096151,0.0063911905,0.10692461,0.0014783893,0.030915828,0.7783514],"study_design_scores_gemma":[0.010974154,0.06404707,0.22011596,0.004103926,0.011005387,0.014825716,0.0005253451,0.032815836,0.1343467,0.0047841975,0.5021142,0.0003415175],"about_ca_topic_score_codex":0.0005120978,"about_ca_topic_score_gemma":0.000931735,"teacher_disagreement_score":0.0039306586,"about_ca_system_score_codex":0.0006875582,"about_ca_system_score_gemma":0.0007558906,"threshold_uncertainty_score":0.013149381},"labels":[],"label_agreement":null},{"id":"W4399125390","doi":"10.1080/17425255.2024.2362190","title":"Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Drug; Pharmacogenetics; Medicine; Pharmacology; Epilepsy; Biology; Genetics; Genotype; Psychiatry; Gene","score_opus":0.03801018489628528,"score_gpt":0.40443367718177314,"score_spread":0.3664234922854879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399125390","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008837703,0.09462681,0.00026985712,0.060818553,0.8398614,0.000033191456,0.00018056824,0.00007041356,0.004050834],"genre_scores_gemma":[0.00062919216,0.058823016,0.00017879058,0.035489727,0.896478,0.000022456361,0.00012709746,0.000030730553,0.008221049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838805,0.0003267783,0.00016974146,0.00022367915,0.0007715668,0.00012014476],"domain_scores_gemma":[0.9944818,0.0027113121,0.00040786032,0.00008793796,0.001850249,0.00046093602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025951664,0.0017915018,0.0021006374,0.0014663299,0.00094646314,0.0020804468,0.002335498,0.0071902024,0.015496903],"category_scores_gemma":[0.008299201,0.0005015504,0.0014144166,0.00079587696,0.0009962693,0.002757208,0.00090521795,0.009793314,0.01036345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058628037,0.000009444515,0.00003098285,0.00062899035,0.000023450197,0.00010310119,0.000009898115,0.000016182077,0.00007751163,0.00030657728,0.98065037,0.01808482],"study_design_scores_gemma":[0.000097008844,0.000046645826,0.0003053749,0.0012328717,0.00011253588,0.0005832071,0.000023049839,0.00007368671,0.000099987104,0.0010354149,0.996376,0.000014238375],"about_ca_topic_score_codex":0.0011667797,"about_ca_topic_score_gemma":0.0030500598,"teacher_disagreement_score":0.015496903,"about_ca_system_score_codex":0.0010805597,"about_ca_system_score_gemma":0.0015270959,"threshold_uncertainty_score":0.051842332},"labels":[],"label_agreement":null},{"id":"W4401956103","doi":"10.1080/17425255.2024.2398631","title":"Analgesic medication considerations for chronic pain management post-bariatric surgery","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Medicine; Analgesic; Chronic pain; Obesity; Pain management; Surgery; Pharmacokinetics; Obesity Surgery; Management of obesity; Anesthesia; Gastric bypass; Weight loss; Internal medicine; Physical therapy","score_opus":0.06564633092785836,"score_gpt":0.36827928298022233,"score_spread":0.30263295205236396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401956103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012282167,0.9969025,0.00012523505,0.0014142345,0.00030345333,0.000011543779,0.000028637223,0.0000056966232,0.0010858577],"genre_scores_gemma":[0.0019793827,0.9953727,0.00039384252,0.0012404794,0.00042676996,0.000017160624,0.00005139551,0.0000016732455,0.00051659293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999361,0.00017381721,0.00013336373,0.00006676137,0.00023544216,0.000029721394],"domain_scores_gemma":[0.9988438,0.0006346691,0.0002587719,0.000015908066,0.00022066952,0.000026262907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080587354,0.00053780025,0.0009776778,0.0011687118,0.00023191274,0.0009195257,0.0006446716,0.0012324231,0.005406382],"category_scores_gemma":[0.0025739048,0.00013714812,0.00086021307,0.001008651,0.00034964454,0.0008385877,0.00043711122,0.0013678788,0.0011923539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094873,0.000042980406,0.00032448868,0.05921259,0.00021137709,0.00025900142,0.00008655916,0.000181129,0.0005226809,0.0029066666,0.039326128,0.89683163],"study_design_scores_gemma":[0.00008166607,0.00017763444,0.0032001794,0.08390008,0.00085185166,0.0039176936,0.00020346456,0.00020546558,0.00037568936,0.0039222995,0.90313053,0.000033523327],"about_ca_topic_score_codex":0.0016342042,"about_ca_topic_score_gemma":0.004197966,"teacher_disagreement_score":0.005406382,"about_ca_system_score_codex":0.00056731084,"about_ca_system_score_gemma":0.001788095,"threshold_uncertainty_score":0.018086135},"labels":[],"label_agreement":null},{"id":"W4402396445","doi":"10.1080/17425255.2024.2402931","title":"Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ulcerative colitis; Inflammatory bowel disease; Sphingosine-1-phosphate receptor; Medicine; Pharmacokinetics; Receptor; Inflammation; Sphingosine-1-phosphate; Lymphatic system; Colitis; Immunology; Sphingosine; Pharmacology; Gastroenterology; Internal medicine; Disease","score_opus":0.04156229492358085,"score_gpt":0.3682035273440492,"score_spread":0.3266412324204684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402396445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012196227,0.99888486,0.000057186113,0.00026265657,0.00012493087,0.0000047846884,0.000020693433,0.000003354914,0.00051959074],"genre_scores_gemma":[0.0012643895,0.9977908,0.00012208059,0.00025847074,0.00017560722,0.0000076240294,0.00003463492,0.0000012609418,0.00034507902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.000051622384,0.0000336956,0.00003426065,0.00007614938,0.0000157091],"domain_scores_gemma":[0.9996375,0.00017789932,0.000080867285,0.0000051851375,0.00007891351,0.000019643969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004993996,0.0004765334,0.0010939003,0.0011151173,0.00011096118,0.0006254194,0.00059608446,0.00088533066,0.003655068],"category_scores_gemma":[0.000955375,0.00013088819,0.00056674634,0.0012175211,0.0001844749,0.0005376731,0.00026665276,0.00097387074,0.0013493983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022093707,0.00004419331,0.00014535314,0.03957554,0.00021894756,0.00022527855,0.00003582182,0.00035657335,0.0015590205,0.001171861,0.02372636,0.93272007],"study_design_scores_gemma":[0.00018038525,0.00049360015,0.0019078729,0.020314159,0.00094231206,0.0028882017,0.0000802886,0.00028089748,0.0011514457,0.0017789123,0.9699444,0.00003753638],"about_ca_topic_score_codex":0.00070643553,"about_ca_topic_score_gemma":0.001529463,"teacher_disagreement_score":0.003655068,"about_ca_system_score_codex":0.0004159033,"about_ca_system_score_gemma":0.00074693916,"threshold_uncertainty_score":0.012227476},"labels":[],"label_agreement":null},{"id":"W4402887948","doi":"10.1080/17425255.2024.2409257","title":"A high-throughput liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of <i>p</i> -cresol sulfate, <i>p</i> -cresol glucuronide, indoxyl sulfate, and indoxyl glucuronide in HepaRG culture medium and the demonstration of mefenamic acid as a potent and selective detoxifying agent","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromatography; Glucuronide; Chemistry; Tandem mass spectrometry; Sulfate; Mass spectrometry; Liquid chromatography–mass spectrometry; Metabolite; Biochemistry","score_opus":0.025345942086743768,"score_gpt":0.33122519156549574,"score_spread":0.30587924947875195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402887948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49060372,0.0077180797,0.4786451,0.0008294185,0.00043313313,0.0019579718,0.0076537426,0.005387577,0.00677126],"genre_scores_gemma":[0.6000775,0.005205435,0.37257862,0.0013764265,0.00023248428,0.0031285463,0.0072177146,0.00022876299,0.0099545065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983531,0.00021635304,0.00011045301,0.00036479766,0.0008672034,0.000088029585],"domain_scores_gemma":[0.9994254,0.00010816695,0.00015868396,0.000051601666,0.00017966697,0.00007646887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078771927,0.0014778136,0.0007088782,0.0015577653,0.00072003,0.0007004721,0.0008327188,0.001325011,0.000980827],"category_scores_gemma":[0.00091207516,0.00053739187,0.00067774014,0.00094374554,0.0005312253,0.00062450656,0.0005665948,0.0010580795,0.0010474195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007928914,0.00012442745,0.000913251,0.000072504896,0.0000351779,0.00008684994,0.000024367577,0.00015245358,0.9936101,0.000093366114,0.00020335606,0.0046048653],"study_design_scores_gemma":[0.000022965965,0.00030596738,0.004645451,0.00001647883,0.0000462013,0.0006481621,0.000022436952,0.0049172197,0.98716694,0.000090187285,0.0020837146,0.000034260134],"about_ca_topic_score_codex":0.0008433283,"about_ca_topic_score_gemma":0.00262136,"teacher_disagreement_score":0.0015577653,"about_ca_system_score_codex":0.00069191336,"about_ca_system_score_gemma":0.0011533727,"threshold_uncertainty_score":0.005020261},"labels":[],"label_agreement":null},{"id":"W4403339404","doi":"10.1080/17425255.2024.2416046","title":"Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Menopause; Vasomotor; Medicine; Pharmacokinetics; Internal medicine; Intensive care medicine","score_opus":0.1233456784571422,"score_gpt":0.46358336808257494,"score_spread":0.34023768962543277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403339404","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5746442,0.37626642,0.014559523,0.005967936,0.0012385235,0.0013176496,0.0048698722,0.00050554314,0.02063035],"genre_scores_gemma":[0.9044323,0.07931655,0.0063245273,0.0017506401,0.00047668978,0.00033031538,0.0021829351,0.00009056621,0.0050953873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997527,0.00009501326,0.000023826187,0.000050826824,0.000058816488,0.000018764864],"domain_scores_gemma":[0.99960226,0.0001340614,0.00014910512,0.000018138046,0.000061169165,0.00003536643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046570777,0.0002756171,0.00060499273,0.00025094431,0.00013730266,0.0005177295,0.00032664,0.0005093849,0.005139952],"category_scores_gemma":[0.001115757,0.0001289273,0.00054661685,0.00020199188,0.0001794744,0.00033022763,0.00014843243,0.00080755673,0.0008293501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023559418,0.0016844159,0.0060039745,0.009668388,0.0010836842,0.0019786058,0.00038089787,0.0027880948,0.27813673,0.0019771988,0.01741892,0.65531963],"study_design_scores_gemma":[0.017364021,0.11498636,0.055113506,0.0034840428,0.0050359494,0.026877709,0.0005377407,0.015792971,0.20322572,0.0029331732,0.55427134,0.00037752208],"about_ca_topic_score_codex":0.00029953037,"about_ca_topic_score_gemma":0.0007363268,"teacher_disagreement_score":0.005139952,"about_ca_system_score_codex":0.0002803689,"about_ca_system_score_gemma":0.00032298814,"threshold_uncertainty_score":0.017194808},"labels":[],"label_agreement":null},{"id":"W4406732440","doi":"10.1080/17425255.2025.2455388","title":"A comprehensive update on the <i>human leukocyte antigen</i> and idiosyncratic adverse drug reactions","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Immunology; Medicine; Antigen; Adverse effect; Human leukocyte antigen; Drug reaction; Pharmacology","score_opus":0.057163220520414754,"score_gpt":0.3722387474770187,"score_spread":0.3150755269566039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406732440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011337306,0.9973683,0.00007891937,0.0006041275,0.00047634207,0.00001274716,0.00010313013,0.000008568754,0.0012345557],"genre_scores_gemma":[0.0006808597,0.9976108,0.00019126569,0.0004947721,0.0003527341,0.000011190362,0.00012333234,0.0000017479614,0.0005333438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99946886,0.00011414083,0.00013855328,0.000056423898,0.00018624337,0.0000358107],"domain_scores_gemma":[0.9984724,0.0008563527,0.00029067852,0.000028357626,0.0003011576,0.000051073184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008361186,0.0007905399,0.0015379054,0.0037974599,0.00025707675,0.0010175771,0.00082490843,0.001036893,0.010371983],"category_scores_gemma":[0.002292714,0.00022921125,0.0013990087,0.0032761577,0.00025950046,0.0012075308,0.0006182401,0.0012104212,0.0017146138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011276136,0.000055196688,0.0004006409,0.13867076,0.00043297475,0.00037924352,0.0001541787,0.00026310023,0.0008467214,0.0020134407,0.09706234,0.75960857],"study_design_scores_gemma":[0.000034489847,0.00011588676,0.0019851571,0.06697149,0.0011737418,0.0023930233,0.00009241421,0.00008936351,0.0001920452,0.0012952073,0.92563206,0.000025023577],"about_ca_topic_score_codex":0.0017207338,"about_ca_topic_score_gemma":0.003802646,"teacher_disagreement_score":0.010371983,"about_ca_system_score_codex":0.00068388553,"about_ca_system_score_gemma":0.002241107,"threshold_uncertainty_score":0.03469771},"labels":[],"label_agreement":null},{"id":"W4407067743","doi":"10.1080/17425255.2025.2461484","title":"Evaluating the synergistic use of advanced liver models and AI for the prediction of drug-induced liver injury","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Innovative Medicines Initiative; Ontario Institute for Cancer Research; Robert Bosch","keywords":"Liver injury; Drug; Medicine; Pharmacology","score_opus":0.3582357515422824,"score_gpt":0.5096603489358854,"score_spread":0.15142459739360303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407067743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065558096,0.9580631,0.025534784,0.0029166667,0.00065881346,0.0001741656,0.0009435006,0.00028406212,0.004869096],"genre_scores_gemma":[0.075522214,0.88844347,0.028695513,0.0018625786,0.0007687461,0.00023380858,0.0016353041,0.000080633654,0.0027576657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993149,0.0002633067,0.0000584277,0.00012390927,0.00020996845,0.000029474737],"domain_scores_gemma":[0.9980703,0.001222955,0.00021463845,0.00005195212,0.0003867121,0.00005349952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002378308,0.0012325448,0.0016011114,0.0014498001,0.000117811076,0.0013432032,0.0009290396,0.0011471197,0.002988518],"category_scores_gemma":[0.00428976,0.00025868008,0.0018281309,0.0008172675,0.00021666115,0.00074929214,0.00050281,0.0012510278,0.0011609575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003074781,0.00015210459,0.0031662297,0.017041383,0.001824438,0.0001521098,0.000042616393,0.019615436,0.0038985254,0.0032329853,0.014852514,0.9357141],"study_design_scores_gemma":[0.0005078912,0.0039339457,0.022615029,0.02947723,0.01298638,0.0031230939,0.00025831154,0.17662647,0.022872573,0.032056782,0.6950957,0.00044659694],"about_ca_topic_score_codex":0.001637836,"about_ca_topic_score_gemma":0.002901179,"teacher_disagreement_score":0.002988518,"about_ca_system_score_codex":0.0005466499,"about_ca_system_score_gemma":0.00095758267,"threshold_uncertainty_score":0.012577891},"labels":[],"label_agreement":null},{"id":"W4408000469","doi":"10.1080/17425255.2025.2474128","title":"Safety of concomitant use of oral anticoagulants and antidiabetic drugs: a systematic review of observational studies","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University","funders":"","keywords":"Observational study; Concomitant; Medicine; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.24613544026923098,"score_gpt":0.4566322035657498,"score_spread":0.2104967632965188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408000469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033316878,0.993978,0.00028808368,0.00040720473,0.00013334905,0.00028752157,0.0013400171,0.0000075787825,0.00022645506],"genre_scores_gemma":[0.063244015,0.92902696,0.002498001,0.0015093413,0.0003925403,0.0016854996,0.00148845,0.000014951364,0.00014026107],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9572107,0.014252721,0.020387752,0.002926709,0.0047208928,0.00050116255],"domain_scores_gemma":[0.8061412,0.1318602,0.049172662,0.0036661772,0.008420624,0.0007391279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025433252,0.0012098748,0.0075774095,0.010776055,0.00065362616,0.0024256953,0.0017303613,0.0018759301,0.0032914102],"category_scores_gemma":[0.10976934,0.0012442998,0.006053487,0.012823478,0.0013126507,0.0020848361,0.0012444147,0.00093251694,0.00028854565],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031311627,0.000014692442,0.0074723377,0.95061934,0.015537786,0.00010009686,0.0002120209,0.00008820797,0.00021249254,0.00020378381,0.0011866456,0.024039607],"study_design_scores_gemma":[0.0005440325,0.00034156945,0.032314762,0.8523007,0.093760066,0.0006366565,0.0003808984,0.000115254465,0.0003228294,0.0006596178,0.01855882,0.000064843436],"about_ca_topic_score_codex":0.004696025,"about_ca_topic_score_gemma":0.010397333,"teacher_disagreement_score":0.025433252,"about_ca_system_score_codex":0.0027367545,"about_ca_system_score_gemma":0.008848171,"threshold_uncertainty_score":0.13450551},"labels":[],"label_agreement":null},{"id":"W4409603286","doi":"10.1080/17425255.2025.2495955","title":"DILI prediction in drug development: present and future","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Drug development; Drug; Medicine; Intensive care medicine; Pharmacology","score_opus":0.11548341045726622,"score_gpt":0.4469003716693024,"score_spread":0.3314169612120362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409603286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023909923,0.99620664,0.0005390846,0.001287796,0.00027870666,0.000010669358,0.00006592093,0.000025999547,0.0013460611],"genre_scores_gemma":[0.0037438744,0.9931063,0.000731605,0.0008204558,0.00042957516,0.000017059532,0.00013539605,0.000006115301,0.0010096183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954695,0.000121455356,0.00004638688,0.000088349356,0.00015459403,0.000042329688],"domain_scores_gemma":[0.9987514,0.00059100933,0.00020981043,0.000025058785,0.00034488787,0.000077837736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013721576,0.0008736873,0.001914715,0.0014769532,0.00015659082,0.0014406308,0.0010318805,0.0014098583,0.0067706457],"category_scores_gemma":[0.0019440156,0.00030647908,0.0008782399,0.0012664673,0.00040213604,0.0013442028,0.00057503936,0.0019129545,0.0029059614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001026691,0.000046742316,0.00045896327,0.009205978,0.00017492841,0.00008726678,0.000022161737,0.00091925025,0.00048614905,0.003100182,0.025965132,0.9594305],"study_design_scores_gemma":[0.000095330026,0.00036532947,0.0022476492,0.013131872,0.0007053242,0.0012892673,0.000083527826,0.002412641,0.0010065809,0.009543296,0.9690536,0.00006551074],"about_ca_topic_score_codex":0.0014099933,"about_ca_topic_score_gemma":0.0021826841,"teacher_disagreement_score":0.0067706457,"about_ca_system_score_codex":0.00086538214,"about_ca_system_score_gemma":0.0013023943,"threshold_uncertainty_score":0.022650063},"labels":[],"label_agreement":null},{"id":"W4412413467","doi":"10.1080/17425255.2025.2535177","title":"The on-going quest for a long-acting oral form of levodopa","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Parkinson Canada; Weston Brain Institute; Canadian Institutes of Health Research; Parkinson Québec","keywords":"Levodopa; Medicine; Psychology; Intensive care medicine; Business; Pharmacology; Disease; Internal medicine; Parkinson's disease","score_opus":0.06573145670085147,"score_gpt":0.40516379030027605,"score_spread":0.3394323335994246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412413467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019479486,0.9929832,0.000378585,0.0023044136,0.00077825267,0.000008091542,0.00005022494,0.000017691482,0.003284702],"genre_scores_gemma":[0.0014477513,0.99367046,0.00044843575,0.0013936285,0.00061998115,0.000010625016,0.00008239435,0.0000062114045,0.002320416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997545,0.00004520036,0.000021438751,0.000045252287,0.000115168834,0.000018473518],"domain_scores_gemma":[0.99967515,0.00012475872,0.000049965707,0.000011766761,0.00011642174,0.000021933321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428836,0.0005386121,0.0008980912,0.0008047935,0.00019791171,0.00094634766,0.0006441689,0.0012815594,0.007279512],"category_scores_gemma":[0.0008503315,0.00014291154,0.00058247097,0.0006698613,0.00040149136,0.0012567305,0.0004935803,0.00247675,0.004466569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007583144,0.00003685684,0.00009421827,0.0125053,0.00007393809,0.00015010432,0.000048616475,0.00016579655,0.0027008639,0.00653745,0.060741372,0.91686964],"study_design_scores_gemma":[0.000012785759,0.000056950565,0.00023873041,0.0026898892,0.00005056861,0.0006848683,0.000028448696,0.000051052157,0.00034412538,0.0017002778,0.9941341,0.000008246727],"about_ca_topic_score_codex":0.0008911068,"about_ca_topic_score_gemma":0.0014841364,"teacher_disagreement_score":0.007279512,"about_ca_system_score_codex":0.00045784653,"about_ca_system_score_gemma":0.0007545908,"threshold_uncertainty_score":0.024352431},"labels":[],"label_agreement":null},{"id":"W4413877191","doi":"10.1080/17425255.2025.2556409","title":"Paternal exposure to antiseizure medications and offspring outcomes: a systematic review and meta-analysis of observational studies","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Meta-analysis; Medicine; Offspring; Internal medicine; Pregnancy; Biology; Genetics","score_opus":0.23170884852059573,"score_gpt":0.48377573816506075,"score_spread":0.252066889644465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413877191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038464104,0.99460226,0.0004235575,0.00019573272,0.00007801504,0.00011041037,0.0005979171,0.000009872136,0.00013582857],"genre_scores_gemma":[0.12395452,0.86997855,0.0030432413,0.00073121564,0.0003040104,0.00082993694,0.0009951846,0.00002374264,0.00013948961],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98399264,0.007549794,0.005123683,0.0013865927,0.0016265655,0.00032065195],"domain_scores_gemma":[0.9504034,0.03772635,0.008319842,0.0012889077,0.0019799802,0.0002815283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017529165,0.0019143971,0.012873178,0.008700874,0.0006056285,0.0031887537,0.001579397,0.0014235523,0.002756044],"category_scores_gemma":[0.045748286,0.0012520833,0.022047307,0.008544852,0.0006574914,0.0015254247,0.0012551389,0.0013644061,0.00019137947],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011234176,0.000025345691,0.018335626,0.5046423,0.45391023,0.0001702371,0.00012776382,0.00046651997,0.00031056275,0.00021987551,0.00071713934,0.019950908],"study_design_scores_gemma":[0.00048501632,0.00026103953,0.022845002,0.0813011,0.8895386,0.00029515408,0.000092507944,0.00027517814,0.00022672847,0.00052476034,0.004113751,0.00004115018],"about_ca_topic_score_codex":0.0048896796,"about_ca_topic_score_gemma":0.010190939,"teacher_disagreement_score":0.017529165,"about_ca_system_score_codex":0.0017376158,"about_ca_system_score_gemma":0.003824998,"threshold_uncertainty_score":0.09270418},"labels":[],"label_agreement":null},{"id":"W4416274157","doi":"10.1080/17425255.2025.2592133","title":"The clinical implication of inflammation-driven regulation of drug-metabolizing enzymes","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Enzyme; Disease; Glycolysis; Immune system","score_opus":0.08362478333396023,"score_gpt":0.4659520106390106,"score_spread":0.38232722730505037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416274157","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00848415,0.81355786,0.010512804,0.14274983,0.009647077,0.000056903915,0.00087749085,0.00021721578,0.013896661],"genre_scores_gemma":[0.12574892,0.78962135,0.0057600867,0.03991975,0.030319553,0.00011170521,0.000758229,0.00006750124,0.007692882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989899,0.00029429415,0.000063622334,0.00016413885,0.00036350638,0.00012457266],"domain_scores_gemma":[0.9980702,0.00087820744,0.0002736093,0.00006267308,0.00053981267,0.00017554953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016015527,0.00045716536,0.0009887057,0.00030156277,0.00018714675,0.0015397897,0.00065480836,0.0020793492,0.0049727145],"category_scores_gemma":[0.0028414542,0.00011655468,0.0005442773,0.00021432544,0.00079841836,0.0010613868,0.00056716055,0.0030612054,0.0023151273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013073751,0.0002450447,0.005407529,0.0051685926,0.0003375972,0.0019692497,0.00016914577,0.0013010697,0.033964824,0.037843216,0.24376948,0.6685168],"study_design_scores_gemma":[0.00040560396,0.0013792526,0.0090974225,0.0024638246,0.00040857116,0.004322592,0.00032292077,0.0020744088,0.012092394,0.050769255,0.9165773,0.00008647724],"about_ca_topic_score_codex":0.0004944267,"about_ca_topic_score_gemma":0.00088226836,"teacher_disagreement_score":0.0049727145,"about_ca_system_score_codex":0.0006469138,"about_ca_system_score_gemma":0.001053043,"threshold_uncertainty_score":0.016635418},"labels":[],"label_agreement":null},{"id":"W4417524476","doi":"10.1080/17425255.2025.2607017","title":"Abuse liability of dextromethorphan and its combinatory formulation dextromethorphan/bupropion: a pharmacologic perspective","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Dextromethorphan; Perspective (graphical); Abuse liability; Depression (economics); Glutamatergic; Liability","score_opus":0.03561390995299449,"score_gpt":0.39388536799446794,"score_spread":0.3582714580414734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417524476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13461375,0.76108575,0.014682237,0.03949705,0.0013725369,0.00033463407,0.0016335046,0.00024261407,0.046538],"genre_scores_gemma":[0.41395813,0.5512452,0.008552488,0.009895802,0.0026334336,0.00023661199,0.00077514676,0.000089343055,0.012613696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992818,0.00025482627,0.000064962755,0.00011008516,0.00022885151,0.000059564874],"domain_scores_gemma":[0.99920064,0.00029717575,0.0002683436,0.00003337369,0.0001581252,0.00004222827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000951581,0.00037857925,0.0005331277,0.0004559902,0.00021216576,0.0010336471,0.0005636984,0.0009330293,0.00557175],"category_scores_gemma":[0.0014904978,0.00015957242,0.00061543344,0.000283967,0.0005579242,0.00091704563,0.0005206649,0.0015251248,0.0010033685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001995762,0.00039676446,0.010274671,0.012350027,0.00052145595,0.004182266,0.0007034237,0.0017883355,0.110727295,0.018688086,0.03213983,0.80623215],"study_design_scores_gemma":[0.00033221568,0.009994664,0.025580786,0.0049990406,0.0010016214,0.037408598,0.001448904,0.004138787,0.07523557,0.017076747,0.8226352,0.00014786249],"about_ca_topic_score_codex":0.0006933705,"about_ca_topic_score_gemma":0.0019217627,"teacher_disagreement_score":0.00557175,"about_ca_system_score_codex":0.00058415555,"about_ca_system_score_gemma":0.0006302326,"threshold_uncertainty_score":0.018639386},"labels":[],"label_agreement":null}]}